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Abstract 
Sensory neuropathy (SN) continues to be a frequent and chalenging neurologic 
complication of HIV infection despite widespread use of modern combination 
antiretroviral therapy (cART). Symptoms of HIV-associated sensory neuropathy (HIV-
SN) are often painful and only partialy mitigated by conventional analgesics. Because 
clinical studies of HIV-SN are limited by the inability to sample key components of the 
sensory pathway, our group has developed a simian immunodeficiency virus 
(SIV)/macaque model to investigate the underlying neuropathologic mechanisms of this 
condition and elucidate new therapeutic strategies. Here, I build upon previous work in 
the macaque model by conducting in depth analyses of multiple components of the 
sensory pathway, namely the epidermal nerve fibers (ENF), spinal cord, and dorsal root 
ganglia (DRG). I show that quantitative techniques for assessing ENF loss, a method 
commonly used to diagnose SN in HIV patients, can be adapted for use in Asian 
macaques. Furthermore, by employing these techniques in both rhesus and pigtailed 
macaques, I have uncovered significant diferences in SIV-induced ENF loss between 
species, highlighting the importance of host factors in determining disease outcomes. 
Focusing on pigtailed macaques, I investigated the efects of SIV infection on the spinal 
cord, which transmits and modulates sensory signals. I found significant glial activation 
and upregulation of proinflammatory mediators in the spinal cords of untreated SIV-
infected macaques, as wel as animals receiving cART. I also demonstrated significant 
corelation between SIV-induced alterations in the spinal cord and the degree of ENF loss 
in untreated animals. Finaly, I sought to gain a comprehensive understanding of the 
molecular alterations occuring at the level of the DRG during acute SIV, a time point 
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that precedes significant ENF decline. Using a combination of RNA and protein analyses, 
I found evidence of significant immune activation, as wel altered expression of enzymes 
related to glutamate metabolism and the oxidative stress response, al of which could 
contribute to early sensory nerve damage. Taken together, this dissertation supports the 
premise that HIV-SN involves neuronal dysfunction at multiple levels of the sensory 
pathway and provides novel insights into mechanisms at play during early phases of 
disease, a time when neuroprotective strategies could be of great clinical benefit. 
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HIV Sensory Neuropathy Background 
Human immunodeficiency virus-associated sensory neuropathy (HIV-SN) is 
curently the most frequent neurologic complication of HIV infection. It afects 
approximately 30-50% of individuals living with HIV, including those receiving efective 
combination antiretroviral therapy (cART) 1,2. The most common clinical manifestation 
of HIV-SN is distal sensory polyneuropathy (DSP), a progressive and often painful 
syndrome characterized by bilateral numbness, tingling and burning sensations most 
pronounced in the feet and lower legs 3,4. In severe cases, sensory abnormalities may 
extend above the knees or involve the hands 5. While HIV-SN is not a life-threatening 
condition, the debilitating pain and parasthesias associated with the disease can 
significantly impair patients’ quality of life. HIV patients with chronic neuropathic pain 
have a greater likelihood of unemployment, dependence in activities of daily life, and 
depressive symptoms 6. Treating HIV-SN is chalenging in that conventional analgesic 
medications such as opioids and anti-inflammatory drugs are often poorly efective in 
aleviating painful symptoms and cary many troublesome of-target side efects 7,8. With 
the number of HIV-infected individuals approaching 37 milion worldwide (WHO), there 
is an urgent need for the development not only of more efective symptomatic treatments 
for HIV-SN, but also of agents aimed at preventing or reversing the underlying sensory 
nerve damage.  
A major reason for the lack of suitable treatments lies in our limited insight into 
the pathologic mechanisms that lead to HIV-SN. While the clinical features are consistent 
with a length-dependent ‘dying back’ of sensory nerve fibers 9, it is uncertain whether 
HIV induces damage primarily to the neuron cel body at the level of the dorsal root 
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ganglia (DRG) or if the inciting pathologic change is primarily damage to the peripheral 
nerve fiber, either of which could ultimately result in a distal axonopathy. Furthermore, 
while we know that HIV is unable to infect neurons productively, it is unclear whether 
the neuronal injury arising in HIV-SN is due to persistent release of neurotoxic products 
by activated macrophages and satelite glial cels (tumor necrosis factor-alpha, IL-1β, 
chemokines), expression of neurotoxic viral proteins such as glycoprotein (gp)41, gp120, 
or Tat, by infected peri-neuronal cels, or an additive combination of these processes 7,10-
13. In addition to PNS alterations, HIV-associated neuroinflammation in the spinal cord 
may also contribute to the generation of pain in HIV-SN through the process of central 
sensitization 14-17. 
Adding to this complexity, it is now clear that several of the ‘d-class’ nucleoside 
reverse transcriptase inhibitors (dNRTIs) including zacitabine, stavudine, and didanosine 
are potently neurotoxic and that use of these agents to treat HIV can lead to antiretroviral 
toxic neuropathy (ATN), a syndrome clinicaly indistinguishable from primary HIV-SN 
18-20. Exposure to protease inhibitors has also been proposed as a risk factor for the 
development of peripheral neuropathy, although this remains a topic of debate 21,22. Dose 
reduction or discontinuation of known neurotoxic antiretroviral drugs is often the first 
step in clinical management of neuropathic signs in HIV patients, and for many patients 
results in symptomatic improvement 5,23. However, the frequency of DSP remains 
unacceptably high despite declining use of dNRTIs, atesting to the ongoing importance 
of primary HIV-mediated PN, as wel as contributions of other proposed risk factors such 
as advancing age, impaired immune status, metabolic abnormalities, and genetic 
predisposition 2,24-27. 
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Studying the pathogenesis of HIV-SN in human patients is limited not only by the 
inability to sample key components of the somatosensory pathway, including the dorsal 
root ganglia and spinal cord, but also the frequency of confounding factors such as cART 
treatment, incomplete adherence, and common comorbidities. Thus, the use of relevant 
animal models of HIV-SN wil be critical to dissect the underlying pathogenesis of this 
disorder and direct the development of new therapeutic strategies. 
 
A Simian Immunodeficiency Virus-Infected Macaque Model of HIV Peripheral 
Neuropathy 
Simian immunodefiency virus (SIV) infected macaques have been widely used to 
study host and viral aspects of HIV infection in humans. The appropriateness of such 
models is underpinned by the close resemblance of macaque immune responses during 
SIV infection to those of HIV-infected individuals, as wel as extensive homology shared 
by SIV and HIV, including the binding of SIV envelope glycoprotein gp120 to the host 
receptors CD4 and CCR5 for viral entry 28. Because SIV models vary widely with respect 
to progression to fulminant AIDS and development of neurologic disease, a refined 
pigtailed macaque model was developed to study SIV-induced CNS disease eficiently. 
This model, which entails simultaneous intravenous inoculation of pigtailed macaques 
with both the neurovirulent molecular SIV clone SIV/17E-Fr and the immunosuppresive 
virus strain SIV/DeltaB670 results in an accelerated and highly reproducible progression 
to AIDS by 84 days post-inoculation with approximately 60-70% of SIV-infected 
macaques also developing encephalitis within this time frame 29,30. The encephalitis 
observed in these animals shares many morphologic similarities with HIV-associated 
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encephalitis including characteristic multifocal perivascular infiltrates of macrophages 
and formation of multinucleated giant cels bearing replicating virus 31,32. Further, this 
model has been useful to study numerous translationaly relevant aspects of SIV-
associated CNS disease such as the efectiveness of neuroprotective agents, relevance of 
biomarkers in the CSF, characterization of neuroprotective MHC class I aleles, 
persistence of neuroinflammation with suppressive cART, and identification of CNS 
latency reservoirs 33-38. 
Recapitulating the neuropathologic features of HIV-SN in rodent models has 
proven chalenging. Because these species are not susceptible to infection by HIV or a 
closely analogous lentivirus, in vitro rodent studies of HIV-SN have required creation of 
transgenic mice expressing HIV gp120 in perineuronal cel populations or direct 
inoculation of viral proteins into the peripheral nerves 17,39,40. To determine whether the 
SIV/pigtailed macaque model could serve as a reliable model for HIV-SN, key 
components of the sensory pathway, including samples of skin from the distal leg, sural 
and sciatic nerves, and somatosensory ganglia including trigeminal and dorsal root 
ganglia, were colected from SIV-inoculated pigtailed macaques and examined at the 
morphologic and molecular level. 
 
Lesions in the Somatosensory Ganglia of Simian Immunodeficiency Virus-Infected 
Macaques 
Studies examining the morphologic changes in both the trigeminal ganglia and 
dorsal root ganglia of SIV-infected pigtailed macaques revealed lesions that closely 
resemble those described in patients with HIV-SN 3,9. Somatosensory ganglia from SIV-
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infected macaques contained multifocal perineuronal inflammatory cels including 
macrophages and lymphocytes. In animals with moderate to severe ganglionitis, there 
was evidence of neuronophagia, characterized by macrophages within the neuronal 
compartment of degenerate neurons, as wel as nodules of Nageote, with neuron cel 
bodies replaced by compact aggregates of satelite glial cels and macrophages. In the 
pigtailed macaque model, neuronal loss in the trigeminal and dorsal root ganglia was 
evaluated using the area fraction fractionator technique, a method to estimate neuron 
density. In both locations, significant neuronal loss was identified in SIV-infected 
macaques at 12 weeks p.i. compared with uninfected control animals 41,42. In the 
trigeminal ganglia, decline in neuronal density was inversely proportional with the extent 
of macrophage infiltration as measured by CD68 immunostaining 41. A similar patern of 
neuropathologic changes and macrophage infiltration into the DRG also has been 
reported in a SIV-infected, CD8 T cel-depleted rhesus macaque model (Macaca mulata) 
43. 
 
Changes in Levels of Viral Replication and Inflammatory Markers Over the Course 
of Simian Immunodeficiency Virus Infection 
To determine the temporal dynamics of SIV replication and associated 
neuroinflammatory changes in the PNS during disease progression, we examined 
somatosensory ganglia from SIV-infected macaques euthanized during acute, 
asymptomatic, and terminal stages of infection. In the trigeminal ganglia, SIV RNA was 
detected by in situ hybridization in 2 of 6 animals euthanized at 7 and 10 days p.i., but 
none (0 of 6) of the animals examined at 21 days p.i. In contrast, at 56 days p.i., viral 
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replication was only detected in one of 6 infected animals 41. This patern, in which low 
levels of SIV replication occurs during acute infection in the somatosensory ganglia, 
folowed by suppression by 21 days and subsequent recrudescence at 56 days, paralels 
the trend reported for SIV replication in the CNS of SIV-infected macaques 44. In the 
dorsal root ganglia, SIV replication was measured by qRT-PCR using SIV gag region 
primers and probe, and was found to be relatively constant among animals euthanized at 
6 through 12 weeks p.i., demonstrating that SIV replication in the DRG is continuous 
throughout the late asymptomatic and terminal stages of infection. At the terminal disease 
time point, approximately 12 weeks p.i., both the TG and DRG of SIV-infected macaques 
contained abundant SIV-infected cels as demonstrated by immunostaining for the 
transmembrane glycoprotein gp41 41,42. Similar to the patern of HIV replication in 
human ganglia 45, SIV-infected cels were observed among infiltrating mononuclear cels 
as wel as the perineuronal compartment. To identify infected cel types, ganglia were 
double immunostained for gp41 and the macrophage marker Iba-1. Laser confocal 
microscopy revealed clear co-localization of SIV gp41 within Iba-1 positive 
macrophages, confirming that macrophages were the predominant infected cel type 41,42. 
To characterize the severity and composition of inflammatory changes in the 
somatosensory ganglia during SIV infection, we performed immunohistochemistry and 
quantitative image analysis on sections of TG and DRG from animals euthanized at 
multiple time points post-SIV inoculation. Immunostaining revealed a resident 
population of CD68-positive macrophages distributed difusely throughout the 
perineuronal compartment in both uninfected controls and SIV-infected macaques. In 
SIV-infected animals, this resident population of perineuronal endogenous macrophages 
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stained more intensely than controls and was accompanied by additional, randomly 
distributed infiltrating CD68 positive cels. Although this immunostaining patern likely 
represents concurent activation of resident macrophages and infiltration by circulating 
macrophages, there are curently no available immunologic markers that can readily 
distinguish between these two populations. Compared to uninfected control animals, total 
CD68 immunostaining was found to be significantly elevated in the DRG of SIV-infected 
macaques by 6 weeks p.i., and remained elevated at 8 and 12 weeks p.i. 42, CD68 
immunostaining was also significantly higher in the trigeminal ganglia of SIV-infected 
macaques at terminal stages compared to control animals (Laast et al. 2007). Contrasting 
with the increase in macrophages, there was modest decline in the number of cytotoxic T 
cels (TIA-1+, CD3+) in the trigeminal ganglia of SIV-infected animals versus uninfected 
controls 41. 
Several recent studies have a proposed a integral role for glial cel activation in 
the induction and maintenance of neuropathic pain, including painful HIV-SN 14,46-48. To 
determine whether satelite glial cels were immune activated during SIV-infection, DRG 
sections were immunostained for glial fibrilary acid protein (GFAP) folowed by digital 
image analysis to measure GFAP expression. GFAP expression was significantly 
increased in SIV-infected macaques at 6 weeks p.i. and remained upregulated at 8 weeks 
p.i. However, in animals euthanized at 12 weeks p.i., median GFAP staining had declined 
to the control animal level 42. These compeling results suggest that satelite glial cel 
activation plays a key role in the pathogenesis of SIV-induced damage to the DRG. 
Further studies in the SIV-infected macaque model may elucidate the functional 
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significance of SGC activation during disease progression, including its association with 
neuronal viability and sensitivity.  
 
Simian Immunodeficiency Virus-Induced Functional Alterations in Peripheral 
Nerves 
In contrast to changes observed in the somatosensory ganglia, we found litle 
morphologic evidence of neuritis or damage to myelinated fibers by examining plastic-
embedded, toluidine blue-stained sections of sural and peroneal nerves 42. A similar 
paucity of lesions in sural nerve biopsies has been reported in HIV neuropathy 5,49. 
Possible explanations for this observation include the extensive length of peripheral 
nerves and multifocal distribution of inflammatory changes, as wel the primary 
involvement of smal, unmeylinated fibers. Given the lack of widespread inflammatory 
lesions in the peripheral nerve, the focus of our investigation of peripheral nerves was 
concentrated on alterations in neurophysiology and corelations between these changes 
and SIV-induced pathology in the DRG. 
Because curent clinical methods of measuring peripheral nerve conduction 
velocity (CV) are relatively insensitive to changes in smal unmeylinated fibers, such 
electrophysiologic studies are often of limited diagnostic value in patients with HIV-SN 
5,49. To circumvent this limitation, we employed an ex vivo teased fiber technique to 
measure CV in single, unmeylinated fibers in the sural nerves from control and SIV-
infected macaques. Electophysiology experiments demonstrated a significant decrease in 
mean C-fiber conduction velocity in SIV-infected macaques by 12 weeks p.i., during late 
stages of the disease. Additionaly, there was strong inverse corelation between mean C-
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fiber CV of SIV-infected animals and the degree of CD68 expression in the DRG 
indicating that the extent of macrophage infiltration in the DRG coresponded closely 
with functional changes in C-fiber conduction properties 42. 
 
Epidermal Nerve Fiber Density Declines with Simian Immunodeficiency Virus 
Infection 
Skin biopsies have proven to be an invaluable tool in the clinical diagnosis of 
smal fiber neuropathies and have largely replaced more invasive sural nerve biopsies for 
the asessment of conditions such as diabetic neuropathy and HIV-SN 50-52. After fixation 
and sectioning, skin sections are immunostained with the pan-neuronal marker PGP9.5 to 
alow visualization and quantification of epidermal nerves fibers (ENF)53. In HIV-
infected patients, decreased ENF density in skin of the distal leg has ben shown to 
corelate with lower CD4 counts, higher viral loads, and the presence of neuropathic pain 
54. To examine whether a paralel decline in ENF density occurs in SIV-infected 
macaques, cutaneous biopsies from footpads were colected at necropsy, immunostained 
for PGP9.5, and analyzed by quantitative image analysis. Compared with uninfected 
control animals, SIV-infected animals exhibited a progressive decline in ENF density 
throughout disease resulting in a significant decrease by 8 weeks p.i. and a marked 
reduction at 12 weeks p.i. 42. Interestingly, rhesus macaques inoculated with the same 
combination of viruses do not develop a decline in ENF density, suggesting that 
additional host factors are involved in PNS damage. 
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Simian Immunodeficiency Virus -induced Impairment of Neurovascular 
Regeneration 
In addition to simulating closely HIV-induced damage to the peripheral nervous 
system, the SIV-infected macaque model has also been used to study the impact of 
infection on the capacity of peripheral nerves to regenerate folowing injury. Similar to 
techniques previously described in man 55, we utilized an excisional intracutaneous 
axotomy model in macaques to study both the normal features of nerve regeneration in 
this species and the afect of SIV infection on this process. Briefly, cutaneous axotomies 
were performed at two-week intervals folowing SIV inoculation using 3mm circular skin 
punches to transect the epidermis and dermis. On the 70th day after the initial axotomy, 
al 3mm punch incision sites were harvested using a 5mm skin punch, producing skin 
samples containing excision sites from 14, 28, 42, 56, and 70 days post-axotomy. 
Samples were then immunostained for the pan-neuronal marker PGP9.5 and the length of 
regenerating epidermal nerve fiber sprouts within the axotomy site was compared to the 
length of normal epidermal nerve fibers located outside of the initial axotomy zone. In 
both SIV-infected and uninfected macaques, epidermal reinnervation was rapid and 
complete by 56 days post-axotomy, which is in contrast to the slower, incomplete 
reinnervation observed in humans folowing this technique 55. However, in SIV-infected 
animals epidermal nerve fiber regeneration was delayed at every time point post-axotomy 
compared to uninfected controls 56. 
Because Schwann cels play a crucial role in guiding axonal regrowth folowing 
injury 57-60, we also assessed the degree of Schwann cel migration into denervated 
epidermis by immunostaining for Schwann cel marker p75 nerve growth factor receptor. 
	   	   12	  
In both control and SIV-infected animals, Schwann cel density was highest at the earliest 
time points post-axotomy and declined at a similar rate in both groups. At every time 
point post-axotomy, SIV-infected animals consistently had lower mean Schwann cel 
density measurements than uninfected controls 56. 
Another key contributor to axonal regeneration folowing injury is the regrowth of 
blood vessels, which travel in close morphologic approximation with nerves forming a 
wel-organized network of neurovascular bundles. Further studies investigating 
neurovascular repair in the pigtailed macaque model revealed that while SIV-infection 
does not afect blood vessel regrowth at cutaneous biopsy sites, expression of vascular 
endothelial growth factor (VEGF) around regenerating neurovascular units, measured by 
immunostaining, is lower in SIV-infected animals compared to controls. Additionaly, a 
strong positive corelation was demonstrated between VEGF expression and the extent of 
ENF regeneration 61. Downregulation of VEGF expression may alter the perivascular 
extracelular matrix such that is less conducive to nerve regrowth. Taken together, these 
results indicate that SIV-infection leads to deficient epidermal nerve fiber regeneration 
and that this impairment is mediated, at least in part, by altered Schwann cel migration 
and decreased VEGF expression along neurovascular tracts. In addition, these studies 
ilustrate that the macaque model can accelerate study of human nerve regrowth biology. 
 
Summary and Project Goals 
As reviewed in Chapter I, SIV-infected pigtailed macaques develop key 
pathologic features of HIV-SN, making this model invaluable for understanding the 
complex molecular mechanisms of this condition and elucidating new therapeutic targets. 
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By sampling and examining key components of the peripheral nervous system at multiple 
time points throughout SIV infection, we have found that the virus infects and immune-
activates perineuronal cels of the somatosensory ganglia during early stages of infection, 
seting the scene for insidious neuronal damage that becomes evident later in the disease 
as decreased neuronal density in somatosensory ganglia, altered C-fiber conduction 
properties, and decreased epidermal nerve fiber density. SIV-infection also impairs the 
regenerative capacity of smal epidermal nerve fibers, a factor that wil be imperative to 
address when designing therapeutic strategies for HIV-SN. 
Another notable outcome of these studies in the pigtailed macaque model is the 
development and refinement of various techniques to assess peripheral nervous system 
integrity. These tools are applicable to studies of HIV-SN and wil be instrumental for 
studies involving non-human primate models of other clinicaly relevant smal fiber 
neuropathies including those associated with diabetes melitus and cancer chemotherapy. 
Chapter I provides detailed descriptions of the methodology and quantitative image 
analysis techniques that our group uses to measure epidermal nerve fiber loss in SIV-
infected macaques and outlines important experimental considerations for ENF studies in 
primates. Specificaly, I address macaque species diferences in the development of 
significant ENF decline during SIV infection, discrepancy in baseline ENF values in 
pigtailed macaques from diferent countries of origin, and the feasibility of longitudinal 
ENF assessment in macaque models.  
In addition sensitization at the level of the peripheral nerves, it is widely 
recognized that functional alterations within the spinal cord, where sensory neurons 
synapse to relay information to the brain, are a critical component in the pathogenesis of 
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neuropathic pain. This is atested to by the efectiveness of some centraly-acting 
medications, such as tri-cyclic anti-depressants and pregabalin, in managing other forms 
of sensory neuropathy 62. Studies addressing the role of spinal cord changes in the seting 
of HIV-SN are few, but a recent series of reports has demonstrated increased glial 
activation, enhanced pro-inflammatory signaling, and elevated concentrations of HIV 
envelope glycoprotein gp120 in the spinal cords of autopsy patients with histories of 
HIV-associated pain when compared to “pain negative” HIV patients 14-16. Consequently, 
I set out to determine whether such potentialy pain-enhancing alterations also occur in 
the spinal cord of SIV-infected macaques and whether these changes persist in the seting 
of viraly suppressive cART. In Chapter II, I show that in untreated SIV-infected 
animals, there was a strong corelation between amount of SIV RNA in the spinal cord 
and expression of the macrophage marker CD68, as wel as key pro-inflammatory 
mediators TNFα and CCL2. In contrast, cART-treated animals showed markedly 
increased spinal expression of the astrocyte activation marker GFAP and enhanced CCL2 
expression, suggesting that spinal glial activation and pro-inflammatory signaling persist 
despite viral suppression and may contribute to neuropathic pain in HIV patients on 
efective cART.  
Another largely unexplored aspect of HIV-SN is the presence of sensory 
abnormalities during acute/early HIV infection. Examination of early pathologic changes 
in the PNS of HIV patients is limited due to the inability to obtain samples of nervous 
tissue prior to autopsy, a point when most patients have died during advanced stages of 
disease. However, a recent clinical study by Wang et al 63 showed that among a cohort of 
cART-naïve men evaluated during primary HIV infection (defined as less than one year 
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since transmission), 35% of patients met diagnostic criteria for SN and 22% had 
symptomatic PN. Our group has also reported significant changes in the PNS of 
macaques euthanized at early time points during SIV infection. These findings include 
significantly increased CD68 expression in the DRG at 10 d.p.i. and significantly 
decreased ENF density by 14 d.p.i. Furthermore, significant ENF loss was found to 
persist despite suppressive cART treatment starting at 12 d.p.i. 64. Taken together, these 
findings in human patients and macaques imply that damage to the PNS occurs early 
during the course of HIV/SIV disease and likely ‘sets the stage’ for development 
neuropathic symptoms as the disease progresses or as potentialy neurotoxic cART is 
initiated. In Chapter IV, I atempt to elucidate possible mechanisms underlying this early 
sensory nerve damage by investigating changes in RNA and protein expression within the 
dorsal root ganglia at 7 d.p.i., a time point during acute infection that proceeds detectable 
increase in DRG CD68 expression and significant ENF loss. I demonstrate that, during 
acute SIV infection, there is significant upregulation in the DRG of genes involved in 
immune activation and signaling, including interferon-stimulated genes, which are 
critical to the early antiviral response. I also found alterations in the expression of genes 
and proteins related to glutamate metabolism and the oxidative stress response, which 
may be related to altered celular metabolism in the DRG in the seting of systemic and 
local immune activation. Furthermore, metabolic stress at the level of the sensory nerve 
cel bodies could contribute to early die-back of distal nerve fibers and render nerve cels 
more vulnerable to cART toxicity.  
HIV-SN is a complex disorder that involves altered nerve function at multiple 
points along the somatosensory pathway, both in the periphery and in the central nervous 
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system. It folows that efective, analgesic treatments for HIV patients with established 
neuropathic symptoms wil likely need to be multimodal and target molecular processes 
related to central sensitization, as wel as inhibiting aberant nociceptive signaling at the 
level of the peripheral nerves. Moving forward, a comprehensive understanding of 
pathologic changes occuring during the early stages of HIV wil alow for the 
development of strategies aimed at mitigating additional damage accrued through the use 























II. Tracking epidermal nerve fiber changes in Asian macaques: tools 
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Abstract 
Quantitative assessment of ENF has become a widely used clinical tool for the diagnosis 
of smal fiber neuropathies such as diabetic neuropathy and HIV-SN. As part of our 
group’s eforts to model and investigate the pathogenesis of HIV-SN using SIV-infected 
Asian macaques, we have successfuly adapted the skin biopsy and immunostaining 
techniques curently employed in human patients, and developed two unbiased image 
analysis techniques for quantifying ENF in macaque footpad skin. This chapter provides 
detailed descriptions of these tools and techniques for ENF assessment in macaques and 
outlines important experimental considerations that have become apparent over several 
years of work. Although initialy developed for studies of HIV-SN in the SIV-infected 
macaque model, these methods could be easily translated to a range of studies involving 
peripheral nerve degeneration and neurotoxicity in non-human primates, as wel 
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Introduction 
Transmission of aferent sensory information from the periphery to the CNS is 
accomplished by a variety of sensory nerve types, ranging from the large caliber, thickly-
myelinated fibers that convey the senses of innocuous touch and limb position, to the 
smal-diameter thinly-myelinated Aδ fibers and unmyelinated C-fibers that transmit the 
sensations of temperature and pain 65. Smal fiber neuropathies (SFN) are defined as 
conditions that selectively or predominantly afect the Aδ or C-fibers 66. The clinical 
manifestations of SFN typicaly involve a spectrum of positive and negative sensory 
abnormalities such as neuropathic pain, paresthesias, hyperalgesia, and numbness 52,66,67. 
The etiologies associated with SFN are numerous and include common metabolic 
disorders, such as diabetes melitus 68 and hyperlipidemia 69, infectious diseases such as 
HIV70 and herpesviral infections 71, as wel as rare hereditary 72 and autoimmune 
conditions 73. Relevant to the topic of toxicologic pathology, several pharmaceutical 
compounds, including chemotherapeutic agents 74 and antiretroviral drugs 20,21,64, have 
frequently been associated with peripheral neurotoxicity leading to SFN. For some 
patients, these detrimental side efects can be dose-limiting and negatively impact their 
quality of life 75. Thus, it is imperative to assess the peripheral neurotoxicity of new drugs 
during preclinical testing 76. 
 The diagnosis and study of SFN has historicaly been chalenging 52. Standard 
nerve conduction studies are not sensitive enough to detect abnormalities in smal 
diameter nerve fibers 77. Similarly, morphologic examination of peripheral nerve tissue, 
such as the sural or sciatic nerves, may not reflect early changes to smal fibers that may 
begin in distal regions 78. In recent years, visualization and assessment of ENF in skin 
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biopsies has become a standard clinical tool for the diagnosis of SFN caused by a wide 
variety of conditions 50,79. Unlike quantitative sensory testing, which relies on patient 
responses and is subject to bias 80, ENF analysis is objective and can be applied to animal 
models 81. Skin biopsy is also a relatively quick, noninvasive technique that is applicable 
to longitudinal sampling (compared to sural or sciatic nerve biopsies)82. In several 
conditions, including HIV infection, loss of ENF density has been shown to corelate 
strongly with severity of neuropathic symptoms 83,84. 
 In this report, we describe the development and implementation of skin biopsy as 
a tool to study sensory nerve alterations in SIV-infected macaques. Previous studies by 
our group have shown that SIV-infected pigtailed macaques (Macaca nemestrina) 
develop morphologic and functional lesions of the peripheral nervous system that closely 
paralel those seen in HIV patients with neuropathy 42. These include inflammation, glial 
activation, and viral replication in the lumbar spinal cord 85 and dorsal root ganglia, as 
wel as decreased conduction velocity in isolated C-fibers from the sural nerve 42 Because 
skin biopsy and ENF quantification is curently the gold standard to diagnose and 
monitor SFN in HIV patients and can be performed longitudinaly, we also sought to 
adapt this technique for use in macaques. In addition to pigtailed macaques, we have also 
evaluated ENF of uninfected and SIV-infected rhesus macaques (Macaca mulata), 
alowing for comparison of normative and experimental data between macaque species. 
Through these studies, we have learned valuable lessons regarding skin sample colection 
and processing, quantitative image analysis of ENF, and selection of study animals. 
These lessons are highly applicable to any study evaluating the peripheral nervous system 
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of non-human primates, including preclinical testing of potentialy neurotoxic compounds 
or novel drugs aimed at the treatment of SFN.  
 
Materials and Methods 
Animals 
Juvenile pigtailed macaques (Macaca nemestrina) and adult rhesus macaques (Macaca 
mulata) were inoculated intravenously with a combination of the neurovirulent clone 
SIV/17E-Fr and the immunosuppressive viral swarm SIV/DeltaB670 as previously 
described 86. Age-matched, sham-inoculated animals served as procedural controls. At 
study endpoints, animals were euthanized and whole-body saline perfused prior to the 
colection of tissues. For the pigtailed macaques, which demonstrate an accelerated, 
predictable SIV disease progression 30, specific end points were predetermined according 
to stage of disease [acute disease at 7 and 10 dpi, asymptomatic at 35, 42, and 56 dpi, 
terminal at 84 dpi]. Because the course of disease progression is more variable in rhesus 
macaques, these animals were euthanized when two or more AIDS-defining criteria were 
met (mean length of infection 213 days)87. Al macaques were housed in facilities 
accredited by the Association for the Assessment and Accreditation of Laboratory 
Animal Care International (AAALAS), and al procedures were performed according to 
principles set forth by the Johns Hopkins University Institutional Animal Care and Use 
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Skin biopsy colection and fixation 
Although skin biopsies for ENF analysis in human patients are typicaly obtained from an 
area of the distal leg above the lateral maleolus 66, the high density of hair folicles and 
adnexa present in haired macaque skin necessitated the colection of skin samples from 
non-haired or ‘glabrous’ skin. Thus, we obtained skin samples from the metatarsal 
footpad (between the third and fourth digits) using a 3mm punch biopsy tool at necropsy. 
For studies assessing change in ENF from pre-infection baseline, biopsies were also 
colected prior to inoculation (sham or SIV), and necropsy samples were obtained from 
the opposite foot. Skin sections were fixed for 12 to 24 hours in Zamboni’s fixative (2% 
paraformaldehyde and picric acid) at 4°C, then rinsed with 0.08 mol/L Sorensen’s 
phosphate bufer. Fixed sections were transfered to a cryprotective bufer (20% glycerol 
in 0.08 mol/L Sorensen’s phosphate bufer) and stored at 4°C until processing (typicaly 
within one week).  
 
Immunohistochemistry 
Cryoprotected skin samples were cut perpendicular to the epidermis at a thickness of 
50µm using a freezing-sliding microtome. Each biopsy yielded approximately 60, 50µm-
thick sections, from which 4 representative sections were chosen for immunostaining. 
Individual sections were transfered to 96 wel plates and immunostained for the pan-
axonal marker PGP9.5 (rabbit polyclonal, ABD Serotec, 1:10,000) using a free floating 
section method as previously described 88. Briefly, sections were first bleached with 
0.25% potassium permanganate folowed by oxalic acid to reduce melanin pigmentation. 
The sections were blocked with a solution of 1.0% Triton X-100 (Sigma) with 0.5% 
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powdered milk and 5% normal goat serum in TBS (pH 7.4), then incubated with the 
primary antibody overnight on an orbital shaker at room temperature. The folowing day, 
sections were incubated with a biotinylated secondary antibody (goat anti-rabbit, 1:100, 
Vector), and treated with 1% hydrogen peroxide in 30% methanol/PBS to quench 
endogenous peroxidase activity. Sections were then incubated in avidin/biotin complex 
solution (ABC, Vector Labs, Burlingame, CA) and developed using the Vector SG 
peroxidase substrate kit, which produces dark blue-gray chromogenic staining. Finaly, 
the sections were mounted on alum/gelatin subbed slides, lightly counterstained with 
eosin, and coverslipped with Permount (Fisher).  
 
Quantitative epidermal nerve fiber assessment 
Measurement of ENF density in human skin biopsies is typicaly achieved by manualy 
counting al PGP9.5-stained epidermal nerve fibers that cross the dermal-epidermal 
junction and dividing this number by the linear length of the skin section in milimeters 
88. Although this method is highly sensitive and reproducible in human skin samples 89, 
the remarkably rich sensory innervation of the macaque footpad makes manual counting 
of individual fibers cumbersome and eror-prone. Thus, we developed two quantitative 
image analysis techniques, one based on ENF density and another on ENF length, to 
facilitate ENF assessment in our macaque skin samples. 
 
Measurement of epidermal nerve fiber density 
The method used to determine ENF density in macaque footpad samples was adapted 
from the confocal ‘optical sectioning’ technique described by Kennedy and coleagues 90. 
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Using a brightfield microscope equipped with a Z-axis motor (Carl Zeiss, Oberkochen, 
Germany), Z-stack images were obtained from 15 adjacent, non-overlapping, 400X fields 
for each immunostained skin section. Serial Z-stack images for each field were colected 
at 0.5µm intervals and then colapsed into a single image. Positive PGP9.5 
immunoreactivity was measured as percent region of interest (%ROI) using iVision 
software (BioVision Technologies, Exton, PA). To control for variations in skin section 
thickness, results were normalized to the thickness of each sample (the z distance of the 
stack).  
 
Measurement of epidermal nerve fiber length 
An advantage of quantifying length, rather than density of linear structures in tissue 
sections is the ability to employ non-biased, stereologic image analysis techniques. These 
methods are based on counting random intersections of the object of interest, such as an 
axon or blood vessel, with a geometric probe that is superimposed over the image of the 
tissue 91. Additionaly, stereologic algorithms provide an estimate of the total length of 
objects in a specimen by systematicaly sampling a subset of the total sections, which 
saves time compared to analyzing an entire specimen. To measure length of epidermal 
nerve fibers in macaque footpad samples, we used the Stereo Investigator space bal 
probe (MBF Biosciences, Version 9), similar to the method described by Ebenezer and 
colleagues 92 and 61. Three, 50µm thick, PGP9.5 immunostained skin sections were 
evaluated per animal. For each section, a region of interest (ROI) in the epidermis, 
extending from the dermal-epidermal junction to the stratum corneum, was traced under a 
Nikon 4x/0.2 Plan Apo objective on a Nikon Eclipse E600 light microscope (see Fig 1A 
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for ilustration). Magnification was then switched to a Nikon 60x/1.4 oil Plan Apo 
objective, and total ENF length was estimated by counting intersections of nerve fibers 
with a hemispheric probe that had a 30µm radius and 2µm guard zones (to account for 
tissue iregularity at the edges of the sections). Only nerve fibers that were clearly within 
the epidermis were counted (Fig 1B). Al stereology measurements were obtained using 
Stereo Investigator DAT files and results were expressed as the estimated total length of 
PGP9.5-stained epidermal nerve fibers. 
 
Statistics 
Al statistical analyses were performed using GraphPad Prism software (version 5.0d) 
and nonparametric methods. The Mann-Whitney U test was used for two-group 
comparisons and the Spearman corelation coeficient was used to analyze relationships 




Two ENF quantification methods yield strongly correlative results 
In our SIV/macaque studies, we have found that epidermal nerve fibers can be efectively 
visualized in footpad biopsies by immunostaining thick cryosections with the pan-
neuronal marker PGP9.5. Using these immunostained sections, two diferent image 
analysis techniques, one assessing nerve fiber density and the other measuring fiber 
length, were developed and found to be efective means of objectively quantifying ENF. 
Furthermore, when both quantification methods were applied to the same skin samples, 
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we found strong, direct corelation between the results (Fig 2), showing that either 
technique could serve as a valid tool in other macaque ENF studies. 
 
Species diferences in ENF loss during SIV infection 
The species of macaque used in our group’s SIV work is based on the desired phenotypic 
outcome for each study. Since most of our studies have aimed to model the neurologic 
consequences of HIV infection, the vast majority of our study animals are pigtailed 
macaques, which more quickly and consistently develop SIV-associated CNS and PNS 
disease 30. Smaler numbers of rhesus macaques have been used in studies involving 
HIV-associated cardiac dysfunction, as this species survives longer folowing SIV 
infection and more readily develops functional cardiac abnormalities 93. We have 
colected normative ENF data on uninfected control groups of both pigtailed and rhesus 
macaques. While the median ENF density among control rhesus was lower than that of 
pigtailed macaques, this diference did not reach statistical significance (p = 0.081, data 
not shown). However, in the context of SIV infection, only infected pigtailed macaques 
exhibited a significant decline in ENF density compared to control animals (p = 0.0033, 
Fig 3A). There was no significant diference in ENF density between rhesus macaques 
euthanized at terminal time points and control animals (p = 0.26, Fig 3B). This finding 
demonstrates the potential for considerable variation in host responses between closely 
related primate species, and underscores the need for careful species selection in studies 
evaluating the peripheral nervous system.  
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Macaques of US and Indonesian origin have diferent baseline ENF length  
In addition to considering potential diference in ENF response between species, we also 
examined whether pigtailed macaques from diferent originating countries had 
comparable ENF status prior to entering SIV studies. Interestingly, we found that 
pigtailed macaques imported from Indonesia had significantly lower baseline ENF length 
than macaques born in the United States (p = 0.0048, Fig 4). Whether this observation 
results from genetic or environmental diferences between Indonesian and US pigtailed 
macaque populations is curently unclear. However, this finding suggests that uniformity 
of animal origin may be a critical factor when designing studies evaluating ENF status of 
primates. 
 
Measuring change from baseline alows longitudinal assessment of ENF loss  
Skin biopsies are a relatively non-invasive and repeatable tool for assessing the status of 
peripheral sensory nerves in humans and animal models, and therefore can be used for 
longitudinal assessment of individual subjects. In our more recent macaque studies, we 
colected pre-infection footpad biopsies and quantified baseline ENF lengths that were 
then compared to values obtained from necropsy skin samples. Among pigtailed 
macaques, we found that SIV-infected animals euthanized during terminal disease (84 
dpi) had a median decrease in ENF length of nearly 5x104 µm from their baseline value 
and that this change was significantly diferent from that observed among uninfected 
controls that were also euthanized at 84 days post mock infection (p = 0.0024, Fig 5). We 
believe that this longitudinal manner of ENF assessment produces more reliable data than 
cross-sectional sampling and measurement, and plan to utilize this method in future 
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studies of SIV neuropathy. In addition, longitudinal studies can be used to monitor 
epidermal nerve fiber regeneration in studies of regenerative agents 56 .  
 
Discussion  
When studying any animal model of human disease or toxicity, a major goal should 
be to employ experimental outcome measures similar to those curently used in clinical 
setings. Over the past decade, assessment of sensory nerve fibers in skin biopsies has 
proven to be a sensitive indicator of early damage to distal unmeylinated nerve fibers, 
and has supplanted older methods, such as sural nerve morphometry and 
electrodiagnostic studies, in the clinical diagnosis of HIV-associated sensory neuropathy. 
In line with this advancement, our group has worked to develop and implement 
techniques to measure progressive ENF loss in SIV-infected macaques. The techniques 
described herein for the procurement and immunostaining of footpad skin biopsies and 
unbiased quantitative analysis of ENF have proven to be key assets in our investigations 
of the pathogenesis of SIV-SN 42,85,94 and could easily translate to other types of studies 
evaluating peripheral neurodegeneration and neurotoxicity in non-human primates.  
Our work with both pigtailed and rhesus macaques has revealed important 
experimental variables that need to be considered when planning ENF studies in 
primates. Firstly, we found that although there was no significant diference in footpad 
ENF density between normal, uninfected macaques of the two species, only pigtailed 
macaques exhibited significant ENF loss during the course of SIV infection. ENF density 
in SIV-infected rhesus macaques with terminal disease was not significantly diferent 
from controls. In contrast, Lakritz and coleagues 95 recently reported significant ENF 
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decline in SIV-infected rhesus macaques that were also CD8-lymphocyte depleted. This 
major discrepancy in experimental outcomes between closely-related macaque species 
emphasizes the importance of host response in animal studies of peripheral neuropathy. 
Rodent studies have also revealed marked diferences in the susceptibility of various 
mouse strains to peripheral neuropathy 39. For example, in a study investigating the 
sensitivity of diferent inbred mouse strains to paclitaxel-induced neuropathy, Smith and 
coleagues 96 showed that DBA/2J mice exhibited especialy robust mechanical 
hypersensitivity after exposure to paclitaxel, while the C57BL/6J mice were relatively 
resistant to this change. The influence of genetic background has also been shown to be a 
critical variable in mouse models of diabetic neuropathy 97. 
Secondly, when evaluating pigtailed macaques originating from diferent countries, 
we found that animals from Indonesia had significantly lower baseline ENF length than 
animals born in the United States. Whether this observation is related to genetic or 
environmental factors is not clear. Significant diferences in ENF density have also been 
reported in people of distinct geographic origins 98. A recent study investigating ENF 
density as a marker of neuropathy risk in Thai HIV patients showed that very few 
subjects in that cohort developed neuropathic signs or symptoms despite use of stavudine, 
a known neurotoxic antiretroviral drug that is stil often used in developing countries 99. 
While several factors likely contributed to this finding, the authors note that HIV 
seronegative Thai subjects have higher ENF density compared to published US control 
values, and that this higher baseline ENF density may provide Thai subjects with greater 
“ENF reserve.” Together, our findings suggest that both species and geographic origin 
are important variables to consider when planning studies of peripheral neuropathy in 
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Asian macaques. While these variables are potential confounding factors in preclinical 
studies of peripheral neuropathy in primates, they could ultimately be informative in 
future research aimed at identifying ‘neuroprotective’ host genes and environmental 
factors.  
Finaly, we have shown that by obtaining footpad skin biopsies prior to SIV infection, 
each animal’s ENF measurement at necropsy can then be compared to its own pre-
infection ENF measurement. With this longitudinal sampling method, we were able to 
demonstrate that SIV-infected pigtailed macaques experienced a significantly greater loss 
of distal ENF length compared to control animals at 84 dpi or post mock-infection. By 
using ‘change-from-baseline’ data rather than single, cross-sectional ENF measurements, 
each macaque serves as it’s own control, which helps account for individual variation in 
baseline ENF values. Longitudinal sampling could be of great benefit for ENF studies 
with smal numbers of animals or when uniformity of animals (age, origin, etc.) is not 
possible. 
Given its extensive distribution and anatomic complexity, systematic sampling and 
assessment of the PNS can be chalenging, especialy in large animal models. Skin biopsy 
and subsequent ENF analysis provide relatively simple methods for obtaining 
information about the status of peripheral sensory neurons, and can be performed 
objectively with litle specialized training. Moreover, loss of ENF density is a more 
sensitive indicator of early damage to smal unmeylinated nerves than traditional 
histologic or morphometric nerve analyses. Our group’s eforts to evaluate ENF in the 
context of SIV-associated sensory neuropathy has led to the development of reliable tools 
and unbiased, quantitative techniques that could be applied to a wide range of peripheral 
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neuropathy and neurotoxicity studies in primate species. Additionaly, the noninvasive, 
repeatable nature of the skin biopsy technique makes it ideal for studies of interventional 
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Figure 2-1. Ilustration of the stereologic technique for measuring ENF length in a 
footpad skin biopsy. As depicted in A, the epidermis is traced (light blue outline) in a 
PGP9.5-stained skin section under low magnification. This serves as the region of interest 
(ROI). The Stereo Investigator software then systematicaly selects a subset of fields 
within the ROI for measuring ENF (represented by the black rectangle). After switching 
to high magnification, as shown in B (60X oil objective), the probe is moved through the 
Z-axis of the tissue by a motorized stage and points of intersection between ENF and a 
hemispheric probe (represented by red circle) are marked by the user (blue circles). 
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Figure 2-2. Two ENF quantification methods yield strongly correlative results. Two 
diferent image analysis techniques, one measuring nerve fiber density and the other 
measuring fiber length, were developed. When both quantification methods were applied 
to the same skin samples there was strong direct corelation between the techniques (p < 
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Figure 2-3. Species diferences in ENF loss during SIV infection. Pigtailed macaques 
exhibited significant decline in ENF density at 84 days post SIV infection (A; p = 0.003), 
but there was no significant diference in ENF density between rhesus macaques 
euthanized at terminal SIV time points versus control animals (B; p = 0.26, Mann-
Whitney U test). Photomicrographs of skin biopsies from control (C) and SIV-infected 
(D) pigtailed macaques demonstrate a marked decrease in the number of thin, finely-
beaded PGP9.5-stained nerve fibers in the epidermis. The light blue line delineates the 
region of interest (ROI) for assessing epidermal nerve fibers. Bundles of thicker PGP9.5-
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Figure 2-4. Diferences in baseline ENF length based on country of origin. When 
comparing baseline ENF length of pigtailed macaques originating from diferent 
countries, animals from the United states had significantly higher baseline ENF than 
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Figure 2-5. Measuring change from baseline alows longitudinal assessment of ENF 
loss. Footpad skin biopsies were colected from pigtailed macaques at the time of 
inoculation (SIV or mock) and at necropsy, 84 dpi. ENF length measurements obtained 
from each animal’s necropsy skin samples were compared to measurement from their 
pre-infection samples, and results were ploted as “change from baseline.” SIV-infected 
pigtailed macaques had a median decrease of approximately 5x104 µm, which was 
significantly diferent from the median change observed in uninfected animals, which 
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Abstract 
Studies of neurologic disease induced by SIV in Asian macaques have contributed greatly 
to the curent understanding of HIV pathogenesis in the brain and PNS. However, 
detailed investigations into SIV-induced alterations in the spinal cord, a critical 
sensorimotor relay point between the brain and PNS, have yet to be reported. In this 
chapter, lumbar spinal cords from SIV-infected pigtailed macaques were examined to 
quantify SIV replication and associated neuroinflammation. In untreated SIV-infected 
animals, there was a strong corelation between amount of SIV RNA in the spinal cord 
and expression of the macrophage marker CD68, as wel as key pro-inflammatory 
mediators TNFα and CCL2. We also found a significant corelation between SIV-induced 
alterations in the spinal cord and the degree of distal epidermal nerve fiber loss among 
untreated animals. Spinal cord changes also were present in SIV-infected antiretroviral-
treated animals including elevated GFAP immunostaining and enhanced CCL2 
expression despite SIV suppression. A fuler understanding of the complex virus and host 
factor dynamics in the spinal cord during HIV infection wil be critical in the 
development of new treatments for HIV-associated sensory neuropathies and studies 






	   	   40	  
Introduction 
 Although a multitude of studies thoroughly describe the morphologic and 
molecular alterations that develop in the brain and peripheral nerves of HIV patients and 
SIV-infected macaques 30,41-43,100-103, there have been few detailed analyses of the efects 
of HIV/SIV infection on the spinal cord. The majority of studies that do address HIV-
associated spinal cord disease were published during the pre-combination antiretroviral 
therapy (cART) era, when opportunistic CNS infections, fulminant HIV encephalo-
myelitis, and an enigmatic degenerative condition known as vacuolar myelopathy were 
common findings at autopsy 104-109. While the frequency of serious complications directly 
atributable to spinal cord disease has waned since the deployment of modern cART, 
investigators have recently begun to consider the role of spinal cord alterations in the 
pathogenesis of what is curently the most common neurologic complication of HIV 
infection, HIV-SN. HIV-SN is reported to afect up to 60% of individuals living with 
HIV infection and causes a range of uncomfortable, dificult to manage symptoms 
including “painful numbness” or burning sensations, hyperalgesia, and alodynia 1,6. 
Although the pathogenesis of this condition is incompletely understood, the development 
of chronic neuropathic pain likely involves sensitization peripheraly, at the level of the 
nerves and ganglia, as wel as centrally, within the spinal cord 13. Notably, three recent 
studies by Tang and coleagues demonstrated increased glial activation, enhanced pro-
inflammatory signaling, and elevated concentrations of HIV gp120 in the spinal cords of 
autopsy patients with histories of HIV-associated pain when compared to “pain negative” 
HIV patients 14-16. 
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  In-depth analysis of the HIV/SIV infection in the spinal cord is also highly 
relevant to ongoing investigations of the CNS as a reservoir for residual viral replication 
and latent, integrated provirus in patients receiving cART. It is widely recognized that 
macrophages and microglia, and potentialy astrocytes, in the brain serve as reservoirs for 
viral replication and reactivation, and that neuroimmune activation often persists in the 
brain despite systemic viral suppression 38,110,111. Yet, there are curently no reports 
addressing whether a similar situation exists in the spinal cord. With its positioning 
behind the blood-CNS-barier and a ful complement of potentialy infectable and 
immunoactive glial cels, residual HIV infection of the spinal cord could significantly 
contribute to viral persistence in the CNS and impact therapeutic strategies aimed at viral 
eradication. 
 In the present study, we performed morphologic and molecular analyses of the 
spinal cord in SIV-infected pigtailed macaques. This wel-established animal model has 
been shown to closely recapitulate HIV-induced lesions in the brain and peripheral 
nervous system (PNS) within a consistent time course of 12 weeks 112,113. In contrast to 
human studies, use of macaques alows for comprehensive sampling of key CNS and 
PNS components at progressive time points throughout the course of infection, with and 
without concurent cART, and in the absence of potentialy confounding comorbid 
conditions. Because symptomatic HIV-SN occurs predominantly in patients with 
advanced disease, as wel as patients on cART 25,31, we focused on groups of animals 
euthanized during the terminal stage of SIV infection (84 days post infection) and a group 
of infected animals that received viraly suppressive cART for several months. Individual 
animal’s spinal cord alterations were then compared to PNS changes including loss of 
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ENF density, a commonly used measure of peripheral nerve injury. We hypothesized that 
spinal cords of infected animals would show evidence of neuroinflammation such as glial 
cel activation (microglia and astrocytes), as wel as induction of soluble pro-
inflammatory mediators that have been associated with pain-facilitating signaling 
pathways, specificaly tumor necrosis factor-α (TNFα) and the chemokine CCL2. 
Furthermore, we postulated that certain neuroinflammatory parameters would remain 
elevated in the spinal cords of macaques receiving long-term cART as compared to 
uninfected control animals, similar to persistent neuroinflammation found in the brain of 
cART-treated, SIV-infected macaques. 
 
Materials and Methods 
Animal Studies 
Twenty male pigtailed macaques were intravenously inoculated with both the 
neurovirulent clone SIV/17E-Fr and the immunosuppressive swarm SIV/DeltaB670 as 
previously described 114. Fifteen animals did not receive antiretroviral treatment 
(untreated, SIV-infected group) and were euthanized at 12 weeks post infection (p.i.). 
Five animals were treated with antiretroviral medications beginning at day 12 p.i. and 
were euthanized at approximately 170 days p.i. (long-term cART group). The four-drug 
combination therapy consisted of the nucleotide reverse transcriptase inhibitor tenofivir 
(Gilead), two protease inhibitors, saquinavir (Roche) and atazanivir (Bristol-Myers 
Squibb), and the integrase inhibitor L-870812 (Merck, 115). Doses and routes of 
administration were detailed previously 38. Five additional uninfected pigtailed macaques 
served as untreated, virus-negative controls. At necropsy, the animals were saline-
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perfused and colected tissues were either immersion fixed in Streck tissue fixative 
(Streck Labortories, Omaha, NE) folowed by parafin embedding or snap frozen in 
liquid nitrogen folowed by storage at -80C. The animal procedures in this study were in 
accordance with the principles set forth by the Institutional Animal Care and Use 
Commitee at Johns Hopkins University and the National Research Council’s Guide for 
the Care and Use of Laboratory Animals (8th edition). 
 
Immunohistochemistry 
Immmunohistochemistry was performed on Streck-fixed parafin-embedded sections of 
lumbar spinal cord. Tissues were deparafinized in Histo-Clear (National Diagnostics, 
Atlanta, GA) folowed by rehydration in a gradient series of alcohol. After antigen 
retrieval in sodium citrate bufer with 8-minute microwave treatment, sections were 
washed and then blocked prior to incubation in the appropriate primary antibody dilution 
(CD68, 1:2000; clone KP1, GFAP, 1:4,000; DAKO, Carpinteria, CA; KK41,1:4000, NIH 
AIDS Research and Reagent Reference Program), for one hour at room temperature. 
Sections were then incubated sequentialy in biotinylated secondary multilink antibody 
and horseradish peroxidase-labeled streptavidin (Biogenex, San Ramon, CA). 
Chromogen detection was performed by incubating the sections in the substrate 3.3’-
diaminobenzidine. The sections were then washed, cleared, and coverslipped with 
Permount mounting medium (Fisher Scientific, Pitsburgh, PA). Image acquisition and 
quantification of positive CD68 and GFAP immunostaining were performed using a 
Nikon DS-Ri1 color camera mounted on a Nikon Eclipse 90i microscope and NIS 
Elements software (version AR710). A composite image of an entire transverse section of 
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lumbar spinal cord was created by aligning serial images of contiguous 100X fields. 
Regions of interest (ROI) were traced manualy and the percent of total area occupied by 
positively stained cels was determined for the entire transverse section of spinal cord, as 
wel as the white and gray mater compartments separately.  
 
Immunofluorescent Staining and Confocal Microscopy 
To demonstrate active SIV infection of microglia/macrophages in the lumbar spinal cord, 
we performed fluorescent double-labeling for SIV gp41 and the polyclonal 
macrophage/microglia marker Iba-1 folowed by confocal laser microscopy. The staining 
protocol was similar to that described for immunohistochemistry except that the primary 
antibodies and concentrations were KK41 (1:100) and Iba-1 (1:100, WAKO Lab 
Chemicals, Richmond, VA), and secondary antibodies were fluorescent-tagged AF488 
Goat anti-mouse AF546 Goat anti-rabbit (both 1:100, Invitrogen). Sections were mounted 
using Prolong Gold Antifade reagent (Invitrogen, Carlsbad, CA) and sealed with clear 
nail polish. Colocalization of the resulting green (KK41) and red (Iba-1) fluorescent 
labeling was visualized using a Nikon C1 confocal laser microscope system mounted on 
a Nikon Eclipse TE2000-E microscope.  
 
Quantification of SIV RNA and cytokine mRNA in spinal cord tissue 
Total RNA was isolated from 25 mg of snap frozen tissue from the lumbar spinal cord by 
first extracting with RNA-Stat 60 (Tel-Test Inc, Friendswood, Tx) and chloroform, 
folowed by purification using the MirVana kit (Invitrogen, Carlsbad, CA). Genomic 
DNA was removed from the samples using either RQ1 DNase (Promega, Fitchburg, WI) 
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or Turbo DNAse (Invitrogen) according to the manufacturer’s protocols. Al tissue 
samples for RNA isolation were consistently taken from the dorsal half of the spinal cord 
(dorsal to the central canal) and included both white and gray mater. Purified RNA was 
analyzed by real-time PCR using specific primers and probes for SIV gag 114, TNFα and 
CCL2 38. SIV RNA copy number was determined by comparison to a standard curve. 
TNFα and CCL2 gene expression was determined using the ddCt (cycle threshold) 
method 116 with normalization of celular mRNAs to 18s ribosomal RNA levels. Gene 
expression data is reported as fold change relative to that of control animals.  
 
Measurement of Epidermal Nerve Fiber Density 
Ful-thickness skin samples from the plantar footpad were colected from control and 
infected animals at necropsy using a 3mm punch biopsy tool. Sections were obtained 
from an identical location in al animals. Skin sections were then fixed and cryoprotected 
as previously described 42. Cryoprotected samples were sectioned using a freezing-sliding 
microtome to a thickness of 50um and immunostained for the panaxonal marker PGP9.5 
(1:2000; Chemicon, Temecula, CA) as previously described 88. Epidermal nerve fiber 
(ENF) density was measured using a modification of the method described by Kennedy 
et al 117 and McCarthy et al 88. Briefly, 15 adjacent, nonoverlapping colapsed Z-stack 
images were obtained for each immunostained skin section. Serial Z-stack images for 
each microscopic field were colected at 0.5um intervals using a Zeiss microscope 
equipped with a z-motor at 400X magnification (Carl Zeiss, Oberkochen, Germany). 
PGP9.5 immunoreactivity was measured by digital image analysis using iVision software 
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(Version 4.0.14, BioVision Technologies, Exton, PA). To control for variations in 
thickness among sections, results were normalized to the thickness of each skin sample. 
 
Statistics 
Al statistical inferences were calculated using nonparametric methods and GraphPad 
Prism Software (Version 5.0d). Group comparisons were performed using the Mann-
Whitney test. Relationships between variables were determined using the Spearman rank 
corelation. For al analyses, statistical significance was assumed when the P value was 




SIV infection induces morphologic changes in the lumbar spinal cord 
Histopathologic lesions observed in the lumbar spinal cord of untreated, SIV-infected 
macaques were predominantly mild and consisted of modest perivascular infiltrates of 
lymphocytes and macrophages, most notable in the gray mater and meninges (mild 
lesions in n = 6 of 15 animals [40%]). A subset of animals exhibited more severe myelitis 
with lesions similar to those seen in SIV encephalitis including glial nodules (n = 4), 
pronounced perivascular cufing (n = 4, Fig. 1A), and multinucleated giant cels (n = 3, 
Fig. 1B). Interestingly, al animals in which giant cels were observed in the lumbar 
spinal cord also had severe encephalitis. Immunostaining for the macrophage marker 
CD68 and SIV transmembrane glycoprotein 41 (gp41) confirmed that foci of 
inflammation included variable numbers of activated microglia/macrophages often 
harboring SIV (Fig. 1C,D). Confocal laser scanning microscopy of double-stained spinal 
cord sections showed clear co-localization of the macrophage/microglia marker Iba-1 and 
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SIV gp41, demonstrating active SIV infection of macrophage-lineage cels. Histologic 
lesions in the lumbar spinal cords of cART treated animals were limited to minimal 
lymphohistiocytic infiltrates in the meninges. However, in one cART-treated animal there 
was mild, bilateraly symmetrical vacuolization of the lateral white mater tracts 
characterized by frequent, dilated myelin sheaths, similar to changes described in mild 
cases of HIV-associated vacuolar myelopathy 104. 
 
Viral load is directly associated with increasing CD68, but not GFAP expression in the 
lumbar spinal cord of untreated, SIV-infected macaques 
SIV and HIV infection elicit immune activation of resident glial cels in the brain and 
peripheral nervous system, as wel as recruitment of infiltrating macrophages 31,108,113,118. 
Because the extent of glial cel activation is often not appreciated on routine 
histopathologic review, we utilized immunohistochemical staining as a measure of 
macrophage/microglial and astrocytic activation in the spinal cord. In untreated, SIV-
infected animals, there was a significant increase in the amount of CD68 
immunostaining, reflecting macrophage/microglial activation, in the gray mater of the 
lumbar spinal cord compared to control animals (p = 0.045, Fig. 2A) but not white mater 
(p = 0.29, data not shown). Furthermore, there was a direct corelation between SIV RNA 
levels and CD68 expression in both the gray mater (p = 0.027, r = 0.59, Fig. 2C) and 
white mater (p = 0.047, r = 0.54, data not shown). In contrast, there was no significant 
difference in the level of astrocyte activation, as measured by GFAP expression, between 
control and untreated, SIV-infected animals (gray mater: p = 0.089, Fig. 2B; white 
mater: p = 1.0, data not shown) nor was there an apparent relationship between viral load 
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and astrocyte activation (gray mater: p = 0.90, Fig. 2D; white mater: p = 0.20, data not 
shown).  
 
SIV induces expression of soluble pro-inflammatory mediators, TNFα and CCL2, in the 
lumbar spinal cord of untreated, SIV-infected macaques 
The pro-inflammatory cytokine tumor necrosis factor-α (TNFα) and the monocyte-
atracting chemokine CCL2 (also known as monocyte chemoatractant protein-1, MCP1), 
have previously been shown to be elevated in the brain tissue of SIV infected macaques 
38,119. Additionaly, enhanced expression of these molecules in the spinal cord has been 
implicated as a key factor in the genesis of neuropathic pain in a number of rodent 
models 17,120,121. Gene expression analysis by qRT-PCR revealed marked induction of 
these soluble mediators in the lumbar spinal cords of untreated SIV-infected macaques. 
The degrees of both TNFα and CCL2 expression showed strong direct corelation with 
SIV RNA levels (TNFα: p = 0.0011, r = 0.78, Fig 3A; CCL2: p < 0.0001, r = 0.86, Fig. 
3B), as wel as CD68 expression in the lumbar spinal cord (TNFα: p = 0.0064, r = 0.67, 
Fig. 3C; CCL2: p = 0.0066, r = 0.67, Fig 3D). However, there was no significant 
association between TNFα or CCL2 expression with GFAP in the cART-naïve animals (p 
= 0.42 and p = 0.58, respectively, data not shown). 
 
In untreated, SIV-infected macaques, loss of epidermal nerve fibers is associated with 
increasing viral load, CD68, TNFa, and CCL2 expression in the lumbar spinal cord 
Numerous studies have demonstrated the importance of glial activation and enhanced 
cytokine and chemokine signaling within the spinal cord during neuropathic pain 
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syndromes 14,122-124. To investigate the association between pro-inflammatory alterations 
in the lumbar spinal cord during SIV infection with pathologic changes in the peripheral 
nervous system, we compared results of each animal’s spinal cord analyses to its degree 
of epidermal nerve fiber (ENF) loss, which in HIV patients has been shown to corelate 
with the development of neuropathic symptoms 54. Striking loss of ENF density has also 
been previously reported in the accelerated SIV/pigtailed macaque model, with 
significant decline in epidermal innervation by 8 weeks p.i. 42. In untreated, SIV-infected 
macaques, there was a significant inverse corelation between ENF density and spinal 
cord viral load (p = 0.030, r = -0.58, Fig. 4A), CD68 immunostaining (p = 0.014, r = -
0.62, Fig. 4B), as wel as TNFα (p = 0.016, r = - 0.61, Fig. 4C) and CCL2 gene 
expression (p = 0.0091, r = -0.65, Fig. 4D).  
 
Long-term cART treated macaques show elevated GFAP and CCL2 expression in the 
spinal cord without detectable viral replication 
A previous study using the accelerated SIV/pigtailed macaque model 38 demonstrated that 
long-term cART efectively suppressed viral replication in the brain, along with 
normalization of some inflammatory parameters measured, including GFAP and MHC 
class I expression. However, evidence of persistent inflammation was detected in the 
brains of treated animals in the form of elevated CD68 immunostaining and expression of 
interleukin-6 (IL-6), TNFα, and CCL2, al of which failed to return to normal levels with 
treatment. Viral DNA was also detected in the brain tissue of these cART-treated 
animals, suggestive of latent, integrated provirus. Persistent immune activation has also 
been observed in the brains of viraly-suppressed HIV patients in the absence of 
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detectable viral replication, and is thought to play a critical role in the progressive 
neuronal degeneration seen in HIV-associated neurocognitive dysfunction 101,102,125,126. 
As in the brain, SIV RNA was below the level of detection (<100 copies per µg RNA) in 
the lumbar spinal cord of cART-treated animals by qRT-PCR, but there was no 
significant diference in the levels of spinal cord CD68 immunostaining or TNFα 
expression between cART-treated animals and controls (p = 0.11 and p = 0.79, 
respectively, data not shown). Conversely, there was significantly elevated levels of 
GFAP immunostaining in both the gray and white mater of cART-treated animals (p = 
0.016 and p = 0.021, respectively, Fig. 5A-D), as wel as a modest elevation in spinal 
cord CCL2 expression (p = 0.071, data not shown), indicating that these parameters 
remain elevated above control values despite long-term suppressive cART.  
Similar to the untreated SIV-infected macaques, animals treated with long-term cART 
had markedly decreased ENF density at the time of necropsy. We did not find a 
significant corelation between GFAP and epidermal nerve fiber loss among cART-
treated animals (p = 0.92, r = 0.20, data not shown); however, this may be related to the 
smal number of cART treated animals from which parafin-embedded lumbar spinal 
cord was available (n=4). Additionaly, there was no significant association between 
spinal cord CCL2 expression and ENF density among cART-treated animals (p = 0.083, r 
= 0.90, data not shown).  
 
Discussion 
SIV-infected macaques have served as the preeminent animal model for studying HIV 
pathogenesis for over two decades; however, spinal cord neuropathology has not been 
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reported in detail in the SIV/macaque model. Together, our findings demonstrate that the 
spinal cord, like the brain, is an important CNS site of SIV viral replication in untreated 
animals and that a subset of neuroinflammatory changes persist in the spinal cord despite 
viraly-suppressive cART. In untreated animals euthanized during terminal disease (84 
days p.i.), high levels of SIV RNA strongly corelated with increasing expression of the 
macrophage/microglia activation marker CD68 and robust induction of the innate 
immune signaling mediators TNFα and CCL2. These findings are similar to those in the 
brain, and we observed significant corelation between the degree of CD68 expression in 
the lumbar spinal cord and the basal ganglia of these animals (p = 0.014, data not shown). 
In animals that received long-term cART, levels of CD68 immunostaining and TNFα 
gene expression in the spinal cord were not statisticaly diferent from uninfected 
controls, but astrocyte activation, as measured by GFAP immunostaining, was markedly 
elevated along with increased CCL2 gene expression. This is in contrast to findings in the 
brain of cART-treated animals, as previously reported by Zink and coleagues 38, where 
GFAP expression was not significant diferent from control values, but CD68 and TNFα 
expression were elevated.  
   The lesions present in the PNS of HIV patients with sensory neuropathy and SIV-
infected pigtailed macaques have previously been described in detail 42,100,112. It is wel 
recognized that these patients and macaques show evidence of morphologic and 
functional abnormalities of the smal diameter nerve fibers in the periphery, which detect 
and transduce noxious stimuli and conduct nociceptive signals to the CNS, as wel as 
inflammatory changes in the dorsal root ganglia, which house the cel bodies of primary 
aferent sensory neurons. However, it has been proposed that the development of chronic 
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neuropathic pain in HIV patients also involves pathologic alterations in the spinal cord 13, 
where primary aferent neurons synapse with second order aferents and interneurons in 
the dorsal horns, and nociceptive signals are processed and modulated prior to 
transmission to the brain 127. Indeed, many studies using rodent models of nociception 
have clearly established that spinal glial cel activation is a critical and necessary factor in 
the generation of acute and chronic pain 47,128,129. Further, soluble inflammatory 
mediators released by activated glial cels, such as cytokines TNFα, IL-1, IL-6, and 
chemokines CCL2 and CX3CL1 (fractalkine), have been shown to powerfuly modulate 
synaptic transmission of sensory signals in the spinal cord 122-124,130. While the 
physiologic functions of glial activation and enhanced immune signaling may be 
evolutionarily protective in the seting of acute pain and important in the clearance of 
injurious agents and damaged neurons, prolonged immune stimulation and dysregulation 
also may contribute to pathologic pain states.  
HIV infection induces chronic, systemic immune activation that often involves 
the nervous system and is not fuly normalized by the use of viraly-suppressive cART. 
Thus it is not surprising that a large proportion of HIV patients are curently living with 
symptoms of chronic, pathologic pain 23. To investigate this chalenging phenomenon, 
Tang and coleagues have recently published a series of three reports outlining changes 
present in the spinal cord dorsal horns of HIV patients with painful symptoms of sensory 
neuropathy, but absent in HIV-infected individuals without pain 14-16. Alterations in the 
glial activation profile that were specific to ‘pain-positive’ HIV patients included 
elevated GFAP expression, indicative of astrocyte activation, increased production of 
cytokines TNFα and IL-1β, and upregulation of proteins involved in MAPK signaling. In 
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addition, dorsal horns of HIV patients with pain showed evidence of synaptic loss along 
with increases in markers of neuronal activity and plasticity, consistent with the process 
of central sensitization. Interestingly, quantification of HIV viral proteins revealed that 
patients with pain had significantly higher levels of gp120 in the spinal cord dorsal horns 
compared to ‘pain-negative’ patients, but relatively lower levels of Tat, suggesting 
diferential viral gene expression and the potential importance of gp120 specificaly in 
the development of painful symptoms. Intrathecal injection of gp120 in the spinal canal 
of mice resulted in molecular alterations that closely mirored those seen in the HIV 
patients with pain 16. Mice also developed marked spinal macrophage/microglial 
activation, which was not evident in the HIV patients, along with mechanical 
hypersensitivity and progressive decline in ENF density in the hind paws.  
The reported findings in the spinal cords of HIV patients with pain reflect a 
combination of the changes present in the spinal cords of both untreated macaques 
euthanized during terminal disease and in cART-treated animals. This is not surprising 
since the HIV patients in these studies died with clinical AIDS, but also had received 
various antiretroviral drugs throughout the course of their disease. It is widely recognized 
that sensory neuropathy can arise due to neurotoxic efects of certain antiretroviral drugs, 
resulting in a syndrome known as antiretroviral toxic neuropathy (ATN) that is clinicaly 
indistinguishable, and likely often concomitant, with HIV-SN 131. The predominance of 
astrocytic reaction in the spinal cords of HIV patients with pain closely resembles that 
seen in the cART-treated macaques, whereas significant upregulation of pro-
inflammatory mediators is more in line with the untreated macaques that had advanced 
disease. It is possible that astrocyte activation in the spinal cord is associated with toxic 
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neuronal injury rather than a virus-induced inflammatory response. Another explanation 
would be that GFAP expression was elevated in untreated animals at earlier time points 
during the course of disease, but declined during the terminal stage. A distinct patern has 
previously been reported in the dorsal root ganglia of SIV-infected pigtailed macaques, 
where there is an early increase in GFAP expression that is sustained throughout 
asymptomatic infection but wanes by the 84d.p.i. timepoint 42, possibly reflecting the 
progression from a state of sustained glial activation to eventual degeneration and loss. 
Also, although GFAP immunostaining is widely used as a marker of astrocyte activation, 
GFAP expression does not necessarily corelate with functional changes such as altered 
expression of surface receptors, ion channels, or production of cytokines and chemokines, 
which more directly influence pain signaling 122. 
Significant corelations between ENF loss and severity of spinal cord 
inflammation and viral load in the cART-naïve macaques is compeling and, along with 
Tang and coleague’s findings in mice, suggests that chronic stimulation and perhaps 
injury of the central terminus of sensory nerves can contribute to pathologic changes in 
the peripheral nerve fibers. In cART-treated animals, which also exhibited significant 
ENF loss, peripheral nerve damage may be atributable to antiretroviral toxicity rather 
than virus-induced injury to the sensory pathway. Future studies with uninfected, cART-
treated macaques wil be instrumental in dissecting this complex pathogenesis. 
Study of the spinal cord is also germane to another, criticaly important topic in 
contemporary HIV research, viral eradication from the CNS. Several studies have 
demonstrated the presence of low-level viral RNA, integrated viral DNA, and persistent 
immune activation in the brains of HIV patients and SIV-infected primates on 
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suppressive cART, and hypothesized that microglia and infiltrating macrophages serve as 
reservoirs for residual viral replication and reactivation in the CNS 33,38,101,110,111,132,133. 
However, there are curently no published studies addressing whether the spinal cord, a 
major component of the CNS, is also a potential viral reservoir in patients on modern 
cART. Our results show that the spinal cord is an active site of viral infection and 
replication in some cART-naïve animals. Since microglia and infiltrating macrophages 
are also abundant in the spinal cord, studies investigating CNS viral latency and 
persistent neuroinflammation should consider evaluating multiple anatomic locations in 
the spinal cord as wel as the brain. Also, rodent models of acute CNS inflammation have 
revealed major diferences in immune responses, microglial activation, and blood-CNS-
barier breakdown when comparing the brain and spinal cord 134-138. This dichotomy has 
yet to be investigated in a primate model of chronic CNS inflammation, and could have 
substantial impact on the pathogenesis of HIV infection and persistence in the CNS. 
Studies based in the SIV/pigtailed macaque model could investigate the presence of 
residual low-level viral replication, as wel as latent, integrated provirus in macrophages 
and microglia of the spinal cord.  
 Although widespread use of cART has drasticaly reduced morbidity and 
mortality caused by HIV infection, the continued high frequency of chronic neurologic 
complications and pursuit of systemic viral eradication are enduring chalenges. This 
investigation into the neuropathology of the spinal cord of SIV-infected macaques 
demonstrates the importance of considering this key CNS compartment in future studies 
aimed at elucidating the mechanisms underlying painful HIV-SN and the development of 
novel treatment strategies for this debilitating condition. Furthermore, careful 
	   	   56	  
examination of the spinal cord is waranted in the continuing efort to understand CNS 
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Figure 3-1. Morphologic changes in the lumbar spinal cord of untreated SIV-infected 
macaques. While histologic lesions observed in hematoxylin and eosin-stained sections 
of lumbar spinal cord were typicaly mild, a subset of SIV-infected animals showed 
evidence of more severe myelitis, including pronounced perivascular cufing (A) and 
multi-nucleated giant cels (B). Immunostaining for the macrophage marker CD68 and 
SIV gp41 demonstrated that inflammatory foci included numerous activated 
macrophages/microglia (C), that were often infected by SIV (D). Confocal laser scanning 
microscopy was performed in sections of lumbar spinal cord that were double-stained for 
the macrophage marker Iba-1 (D, red) and SIV gp41 (E, green). A composite image (G) 
showed clear colocalization of Iba-1 and SIV gp41, confirming that macrophages in the 
lumbar spinal cord are target cels for SIV infection. Scale bars = (A-D) 100 µm. Original 
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Figure 3-2. Glial activation in the lumbar spinal cord of untreated SIV-infected 
macaques. A: Reflective of enhanced macrophage/microglia activation, untreated SIV-
infected macaques had significantly elevated CD68 immunostaining in the gray mater of 
the lumbar spinal cord compared to control animals (p = 0.045, Mann-Whitney). B: Glial 
fibrilary acidic protein (GFAP) immunostaining, an indicator of astrocyte activation, was 
not significantly diferent between control and untreated SIV-infected macaques (p = 
0.089, Mann-Whitney). C: Similarly, there was a significant, direct corelation between 
SIV viral load and CD68 expression in the spinal gray mater of untreated animals (p = 
0.027, r = 0.59, Spearman rank corelation), but there was no significant relationship 
between GFAP expression and viral load (D) (p = 0.90, r = -0.03, Spearman rank 
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Figure 3-3. SIV induces expression of TNFα and CCL2 in the lumbar spinal cord of 
untreated SIV-infected macaques. A-B: Quantitative reverse transcription PCR (qRT-
PCR) analysis showed strong, direct corelations between SIV viral load and expression 
of the soluble pro-inflammatory mediators TNFα and CCL2 (TNFα: p = 0.0011, r = 0.78; 
CCL2: p < 0.0001, r = 0.86, Spearman rank corelation). C-D: Expression of TNFα and 
CCL2, as measured by qRT-PCR, also showed a significant, direct corelation with the 
degree of CD68 expression in the lumbar spinal cord, indicating that expression of these 
mediators and macrophage/microglia activation are covariant in this group of animals 
(TNFα: p = 0.0064, r = 0.67; CCL2: p = 0.0066, r = 0.67, Spearman rank corelation). 
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Figure 3-4. Among untreated SIV-infected macaques, declining ENF density is 
associated with increasing viral load and neuroinflammation in the lumbar spinal cord. 
To investigate the relationship between SIV infection and pro-inflammatory alterations in 
the spinal cord to pathologic changes in the peripheral nerves, we compared results of 
each animal’s spinal cord analysis to its epidermal nerve fiber density in the footpad. In 
untreated SIV-infected animals, there were significant inverse corelations between ENF 
density and (A) SIV viral load (p = 0.030, r = -0.58), (B) CD68 immunostaining (p = 
0.014, r = -0.62), (C) TNFα expression (p = 0.016, r = -0.61), and (D) CCL2 expression 
in the lumbar spinal cord (p = 0.0091, r = -0.65). Al statistical inferences based on 
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Abstract 
Eforts to explain the continued high prevalence of human immunodeficiency virus HIV-
associated neurologic disorders are increasingly focused on the early stages of infection. 
It has long been recognized that HIV gains entry into the CNS soon after transmission, 
and recent studies have shown compeling evidence that significant CNS immune 
activation, neuronal injury, and cognitive dysfunction arise early during the course of 
infection in many individuals. Comparatively litle is known about the status of the PNS 
during early stages of disease, despite the fact that HIV-SN remains the most frequent 
neurologic complication of HIV. In this chapter, we utilized a wel-established 
SIV/macaque model of HIV-SN to examine molecular alterations occuring within the 
PNS during acute infection. By employing a combination of RNA, protein, and 
immunohistochemical analyses of the lumbar DRG, we found that acute SIV infection is 
associated with significant immune activation in the DRG, as wel as alterations in the 
expression of enzymes related to glutamatergic metabolism and the oxidative stress 
response. Together with our previous finding of significant epidermal nerve fiber loss in 
macaques euthanized at just 14 days post infection, these results suggest that immune 
activation and altered celular metabolism at the level of the DRG precede and likely 
contribute to early sensory nerve injury, thereby seting the stage for progressive neuronal 
dysfunction. A comprehensive understanding of the early pathogenic mechanisms in 
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Introduction 
Sensory neuropathy (SN) continues to be a frequent and chalenging neurologic 
complication of HIV infection despite widespread use of modern cART 1,70. Distal 
sensory polyneuropathy (DSP) is the most common form of PN seen in HIV patients, and 
typicaly presents as numbness, parestethias, and pain of the distal extremities 5,139. 
Although DSP is not a life-threatening condition, the painful symptoms can deleteriously 
affect patients’ quality of life and are often only partialy mitigated by conventional 
analgesic medications 6-8,140. Lack of efective treatment stems from our incomplete 
understanding of the mechanisms underlying sensory nerve injury in the context of HIV 
infection. While autopsy studies have demonstrated increased amounts of viral proteins 
and inflammatory mediators in the DRG and spinal cord of HIV patients with neuropathy 
14-16,141,142, such studies have been limited to patients with late-stage disease. Relatively 
litle is known about PNS damage or dysfunction during early stages of HIV infection, a 
time when interventions aimed at reversing or preventing nerve injury could be prove 
more successful.  
A recent clinical study by Wang and coleagues 63 found that, among a cohort of 
patients with primary HIV infection (defined as <1 year after transmission), 35% of 
individuals had signs of PN and 20% were symptomatic for PN. They also demonstrated 
that the occurence of PN in this cohort was associated with elevated markers of immune 
activation in the plasma and cerebrospinal fluid (CSF), suggesting that PN during early 
HIV infection may be mediated by systemic and nervous system immune responses. 
Importantly, this group underwent detailed neurologic evaluation prior to the initiation of 
cART, which itself can cause antiretroviral toxic neuropathy (ATN), a condition that is 
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clinicaly indistinguishable from HIV-mediated DSP, and often confounds studies of PN 
in HIV patients.  
Similar to these findings in primary HIV patients, previous studies by our group 
have demonstrated alterations in the PNS of simian immunodeficiency virus (SIV)-
infected pigtailed macaques (Macaca nemestrina) euthanized at early time points in the 
course of disease. In a 2007 study by Laast et al., we showed that SIV RNA was 
detectable by in situ hybridization in the trigeminal ganglia of animals euthanized during 
acute and asymptomatic stages of infection 41. Subsequent studies have focused on the 
lumbar DRG, which contain the cel bodies of sensory neurons that innervate the lower 
limbs. We found significantly increased amounts of CD68 immunostaining, a marker of 
macrophage activation, in the DRG of animals at 10 dpi, folowed by significant decline 
in epidermal nerve fiber density (ENFD), a surogate marker for sensory nerve damage, 
at 14 dpi. This suggested that inflammation in the DRG during acute infection might 
contribute to early sensory nerve injury and die-back of distal axons. In addition, 
significant loss of ENFD persisted in a group of cART-treated macaques despite 
initiation of therapy at 12 dpi (end of acute phase) and sustained virologic suppression 
from approximately 50 dpi until necropsy 64, further highlighting the potential importance 
of early sensory nerve damage in the development of PN.  
The observation that CD68 immunostaining is increased in the DRG during acute 
SIV infection and precedes significant losses of ENFD supports the premise that 
macrophage-mediated inflammation in the DRG contributes to early sensory nerve injury 
and degeneration of distal axons. However, while increased CD68 immunostaining is an 
often-used indicator of macrophage activation, it is a relatively nonspecific marker and 
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provides no information regarding the molecular processes leading to or resulting from 
this activation state. In the curent study, we sought to gain a more detailed understanding 
of the immune responses occuring within the DRG during acute SIV infection and to 
identify potential mechanisms for sensory nerve injury. We performed RNA and protein 
isolation on lumbar DRG colected from uninfected macaques, as wel as SIV-infected 
animals euthanized at 7 dpi - the acute time point when plasma and CSF viral loads peak 
folowing SIV inoculation in our model 113. RNA was used for Nanostring nCounter gene 
expression analysis, a technology that alows for the quantification of a large number of 
mRNA transcripts without reverse transcription or DNA amplification 143,144. From the 
Nanostring panel, we focused on genes related to immune signaling and activation, as 
wel as genes involved in glutamate metabolism and oxidative stress, two pathways that 
have been strongly implicated in the pathogenesis of neuronal injury during HIV-
associated neurocognitive disease (HAND) 145-149. Significant novel findings from the 
gene expression analysis were further queried at the protein level by Western blot using 




Six juvenile male pigtailed macaques were intravenously dual-inoculated with the 
neurovirulent clone SIV/17E-Fr and the immunosuppressive swarm SIV/DeltaB670 as 
previously described 114 and euthanized at day 7 post infection (from hereon refered to as 
7d SIV-infected animals). Eight uninfected pigtailed macaques served as controls and 
were euthanized at 12 weeks folowing sham inoculation. At the time of necropsy, 
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animals were whole-body saline perfusion to remove blood from tissue vasculature. PNS 
tissues were dissected and either snap frozen and stored at -80°C until use or fixed in 
Streck tissue fixative (Streck Labortories, Omaha, NE) and embedded in parafin. Al 
animal procedures in this study were conducted with the approval of the Johns Hopkins 
Animal Care and Use Commitee and the National Research Council’s Guide for the Care 
and Use of Laboratory Animals (8th edition). 
 
RNA isolation and gene expression analysis 
Total RNA was isolated from frozen L3 DRG by first extracting with RNA-State 60 (Tel-
Test Inc., Friendswood, TX) and chloroform, folowed by purification using the RNeasy 
kit (Qiagen, Valencia, CA) according to the manufacturer’s protocol, with the inclusion 
of on-column genomic DNA removal using the RNase-Free DNAse Set (Qiagen, Hilden, 
Germany). RNA concentration and purity were measured using a Nanodrop 
Spectrophotometer (Thermo Fisher Scientific, Waltham, MA).  
 
A total of 100 ng of RNA per sample was used for nCounter Gene Expression Assay 
(Nanostring Technologies, Seatle, WA), which was performed according to the 
manufacturer’s protocol by the Johns Hopkins Deep Sequencing and Microaray Core 
Facility. The assay made use of a custom Nanostring Codeset designed to measure 249 
transcripts of interest and 11 putative housekeeping transcripts based on rhesus macaque 
(Macaca mulata) and human sequences. For the purpose of this study, analysis was 
focused on genes involved in immune activation and the early antiviral response (IRF7, 
STAT1, MX1, CCL8, CXCL10, CXCL11), glutamate metabolism (GLS and GLUL), and 
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in the oxidative stress response (SOD1 and SOD2). To account for probe-specific 
background, 100ng of MS2 phage RNA (Roche, Basel, Switzerland) was run in duplicate 
as a negative control.  
 
Nanostring data were analyzed by first adding a value of 1 to al counts (to exclude any 
zero values), normalizing to the geometric mean of manufacturer spike-in controls, and 
normalizing to the geometric mean of the four housekeeping genes that were most stably 
expressed in the DRG among animal groups (GAPDH, SDHA, HRPT1, and TBP). Data 
are reported as normalized transcript counts. The lower limit of detection for each probe 
was set to the mean value for the MS2 phage RNA control +2 standard deviations. Genes 
that had values faling below the limit of detection were excluded from analyses. 
  
Although TNFα was included in the Nanostring panel, counts for control and 7d SIV-
infected animals were low compared to those of other transcripts of interest (< 60 
counts). Therefore, results from the Nanostring analysis were further coroborated by a 
separate qRT-PCR assay. For this, 500ng of RNA was used for complementary DNA 
synthesis using the High Capacity cDNA Reverse Transcription Kit (Applied 
Biosystems, Forest City, CA) folowed by a 10-cycle pre-amplification reaction using 
TaqMan PreAmp Master Mix (Applied Biosystems) according to manufacturer 
instructions. qPCR was then performed using a TaqMan TNFα primer-probe mix 
(Applied Biosystems, Catalogue # Hs01113624_g1) and the TaqMan Universal PCR 
Master Mix. Samples were run in triplicate and relative mRNA expression was calculated 
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using the ΔΔCt method with normalization to 18s ribosomal RNA levels. 18S 
primer/probe sequences have been previously published 116,150. 
 
Protein isolation and Western bloting 
Frozen L6 DRG were homogenized in 0.5% NP-40 lysis bufer supplemented with 
protease and phosphatase inhibitor cocktails (Sigma Aldrich, St. Louis, MO) using a 
FastPrep bench top homogenizer in 2mL tubes containing lysing matrix M (MP 
Biomedicals, Santa Ana, CA). Homogenates were then sonicated (3 times for 10 seconds) 
and centrifuged to remove insoluble material. Protein concentration was estimated using 
the BioRad Protein Assay Kit (BioRad Laboratories, Hercules, CA) according to 
manufacturer instructions. Five micrograms of protein were resolved under reducing 
conditions using 26-wel 10% Bis-Tris gels (BioRad) and 1X MOPS bufer. Proteins 
were transfered to polyvinylidene fluoride (PVDF) membranes, which were 
subsequently blocked in Tris-bufered saline Tween-20 (TBST) containing 5% nonfat dry 
milk. Membranes were then incubated with primary and secondary antibodies listed in 
Tables 1 and 2, washed in TBST, and finaly developed with Pierce ECL Western 
Bloting Substrate (Thermo Fisher) prior to exposure to radiography film. Because 
glutamine synthetase, β II Tubulin, and β-actin have similar molecular weights, the 
membranes were first probed for glutamine synthetase, stripped using Restore PLUS 
Western Blot Stripping Bufer (Thermo Fisher) for 15 minutes at room temperature, then 
re-probed for βII tubulin, folowed by β-actin. Films were digitaly scanned and 
densitomitry analyses were performed using ImageQuant TL 7.0 software (GE Life 
Sciences, Sunnyvale, CA). To account for blot-to-blot variation, a standard DRG lysate 
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was included in each blot for normalization and β-actin expression was utilized as an in-
lane loading control. 
 
Immunohistochemistry 
Indirect, peroxidase-based immunostaining was performed on Streck-fixed sections of L5 
DRG from three control and six 7d SIV-infected animals using the Leica Bond-Max 
automated system (Leica Biosystems, Wetzlar, Germany). The protocol for al antigens 
included pretreatment with Bond TM Epitope Retrieval 2 and heating for 20 minutes, and 
positive immunoreactivity was visualized by labeling with 3,3’-diaminobenzidine (DAB) 
chromogen. Primary antibodies and concentrations are listed in Table 1. Isotype-matched 
non-immune immunoglobulins were employed as negative controls and showed no 
significant staining in DRG tissue. 
 
Statistics 
Al statistical analyses were conducted using Prism software (GraphPad, La Jola, CA, 
Version 5.0d) and nonparametric methods. The Mann-Whitney U test was used for al 
two-group comparisons. For Nanostring data, the statistical significance was set at P < 
0.0042 to account for multiple comparisons (Bonferoni corection). For al other 
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Results 
Quantification of DRG mRNA expression by Nanostring and qPCR analysis 
Immune signaling and activation 
During the acute phase of HIV and SIV infection, high levels of plasma viremia are 
accompanied by an intense systemic cytokine cascade that is thought to contribute to 
immunopathologic consequences of infection 113,143,151. However, litle is known about 
immune responses occuring in the PNS during acute HIV/SIV or the role that such 
responses could plan in early sensory nerve injury. We performed Nanostring analysis of 
immune-related gene expression in the DRG of 7d SIV-infected macaques, as wel as 
uninfected control animals. We found that at 7 days post infection, there was marked 
upregulation of genes related to Type I IFN signaling and the early antiviral response in 
the DRG (IRF7, Mx1, CCL8, CXCL10, and CXCL11) (Fig 1A-F). Because of their 
previously established importance in the pathophysiology HIV and SIV-associated 
disease 35,38,119,152,153, we also examined changes in CCL2 (MCP1) and TNFα gene 
expression in the DRG during acute SIV infection. CCL2 gene expression was elevated 
in 7d SIV-infected macaques compared to controls; however this diference did not reach 
statistical significance after corection for multiple comparisons (p = 0.029, Fig 1G). 
TNFα expression, which was measured by a separate qPCR assay, was significantly 
increased in the DRG at 7 days post SIV infection (p = 0.0024, Fig 1F). We also looked 
at expression of genes related to macrophage (CD68) and satelite glial cel (GFAP) 
activation. By Nanostring analysis, CD68 gene expression was significantly elevated at 7 
days post SIV infection (p < 0.001, Fig 2A). GFAP gene expression was also elevated in 
7d SIV-infected animals, but this did not reach statistical significance after corection for 
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multiple comparisons (p = 0.0047, Fig 2B). These results indicate that there is significant 
local celular immune activation in the DRG at 7 days post SIV-infection, a time point 
that proceeds detectable DRG macrophage activation by CD68 IHC (10 dpi) and 
significant loss of ENFD (14 dpi) 64. 
 
Glutamate metabolism and oxidative stress 
Previous studies have proposed that altered glutamate homeostasis and increased 
oxidative stress contribute to neuronal damage in the brain during HIV-associated 
neurocognitive disease (HAND) 145-148. Thus, to investigate potential mechanisms of 
early sensory nerve damage in the SIV model, we evaluated the expression of genes 
related to glutamate metabolism and the oxidative stress response in the DRG of acutely 
infected and control animals. Nanostring analysis revealed that, in 7d SIV-infected 
animals, glutaminase (GLS1) gene expression was significantly downregulated (p < 
0.001, Fig 3A) compared to uninfected controls, while glutamine synthetase (GLUL) was 
significantly upregulated (p < 0.001, Fig 3B). To assess induction of an oxidative stress 
response in the DRG, we focused on the expression of two distinct isoforms of 
superoxide dismutase (SOD), the first enzyme in the reaction to detoxify the superoxide 
anion. For SOD1, the isoform that localizes to the cytosol, there was no significant 
diference in gene expression between control and 7d SIV-infected macaques (p = 0.081, 
Fig 3C). In contrast, there was significant upregulation of SOD2 RNA, which encodes the 
mitochondrial SOD isoform (p < 0.001, Fig 3D), also known as manganese super oxide 
dismutase (MnSOD). 
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Quantification of DRG protein expression by Western blot 
To extend findings from the RNA analyses to the protein level, Western blots were 
performed that measured expression of glutaminase, glutamine synthetase, and SOD2 in 
DRG homogenates. Densitometry results were normalized to the celular loading control 
β-actin. As shown in an image of a representative blot and graphicaly in Figure 4, there 
was no significant diference in the amounts of glutaminase (p = 0.58, Fig 4B) or 
glutamine synthetase expression (p = 0.23, Fig 4C) in the DRG of 7d SIV-infected 
animals compared to controls. In contrast, the relative amount of SOD2 expression in the 
DRG was elevated in 7d SIV-infected animals (p = 0.0013, Fig 4D), in accordance with 
RNA expression data (Fig 3D). Surprisingly, the amount of βII tubulin expression, 
which is typicaly used as a neuron-specific loading control, was significantly and 
consistently decreased at 7 days post SIV infection (p < 0.001, Fig 5A), while this was 
not evident at the RNA level (p = 0.14, Fig 5B).     
 
Immunohistochemistry 
We performed immunostaining on fixed sections of L5 DRG from control and 7d SIV-
infected macaques to identify which cel types in the ganglia express glutaminase, 
glutamine synthetase, and SOD2 in normal conditions, and to determine whether the 
amount of expression or cel specificity changes during acute SIV infection. Glutaminase 
expression in both control and 7d SIV-infected animals was primarily restricted to the 
neurons, with difuse, moderate to strong cytoplasmic staining of the neuronal cel bodies 
(Fig 6A-B). Scatered interstitial cels, likely macrophages, also showed light cytoplasmic 
reactivity for glutaminase in both control and 7d SIV-infected ganglia. In uninfected 
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animals, glutamine synthetase expression in the DRG was most apparent in the satelite 
glial cels, with litle to no staining in the neuron cel bodies (Fig 6C). In contrast, al 7d 
SIV infected ganglia exhibited moderate glutamine synthetase expression in the 
cytoplasm of neuron cel bodies (Fig 6D). Furthermore, this upregulation in neuronal 
glutamine synthetase expression was primarily observed in smal- to medium-sized 
neuronal cel bodies, a population which is thought to represent nociceptive neurons 154. 
SOD2 immunostaining demonstrated difuse, light to medium cytoplasmic staining in al 
cel types in the DRG, with a finely stippled patern consistent with mitochondrial 
localization (Fig 6E). In 7d SIV-infected ganglia, increased intensity of SOD2 




Previous work in the pigtailed macaque model of HIV-SN has demonstrated that 
immune activation in the DRG corelates with and likely contributes to sensory nerve 
dysfunction during late stages of SIV infection 42. More recently, we found that 
significant DRG macrophage activation and ENFD decline were detectable much earlier 
than previously realized, at just 14 dpi, and that this loss of ENFD persisted in cART-
treated SIV-infected animals despite viral suppression and normalization of CD68 
immunostaining in the DRG 64. The aim the curent study was to gain a more 
comprehensive understanding of molecular alterations in the lumbar DRG during the 
acute phase of SIV infection and to explore potential mechanisms for early neuronal 
injury. 
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By evaluating gene expression in the DRG of animals euthanized during acute 
SIV infection (7 dpi), we found significant upregulation of several genes involved in the 
antiviral immune response, namely IRF7, STAT1, MX1, CCL8, CXCL10, CXCL11, and 
activation of macrophages (CD68), as wel as key pro-inflammatory mediators (TNFα 
and CCL2). Changes were largely uniform among 7d SIV-infected animals and did not 
significantly corelate with the amount of SIV RNA detected in the DRG (data not 
shown), suggesting that local immune activation in the DRG is associated with the rapid 
systemic immune response exhibited by al animals during acute SIV viremia 113 and not 
a result of local SIV replication. Because of their fenestrated capilaries and location 
within the intradural space 155-157, the DRG are readily exposed to proinflammatory 
factors in plasma and CSF such as cytokines, chemokines, and activated leukocytes. 
Therefore, covariance of systemic and local DRG immune activation would not be an 
unexpected finding. Moreover, several of the immune-related genes that were most 
strongly upregulated in the 7d SIV-infected macaques were those induced by interferon 
signaling, which has been shown to play a major role in the early antiviral immune 
responses to both SIV and HIV infection 113,143,150,158-160. 
An association between systemic immune activation and the occurence of PN has 
been observed in patients during the early stages of HIV infection. In a cohort of 
individuals evaluated at a median of 3.5 months folowing HIV transmission, Wang and 
coleagues 63 found that patients with signs of PN had elevated levels of the inflammatory 
marker neopterin in the plasma and CSF, as wel as higher CSF levels of the chemokines 
MCP-1 and IP-10 (CXCL10), both of which enhance viral replication and local 
inflammation by recruiting monocytes and lymphocytes. The authors postulated that, due 
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to the lack of a local blood-nerve-barier, the DRG might be a site where peripheral 
neurons are particularly vulnerable to the toxic efects of circulating proinflammatory 
factors. By evaluating DRG tissues directly, this macaque study complements these 
findings by demonstrating that immune-reactive cels in the DRG are themselves 
undergoing activation during acute SIV infection, expressing cytokines and chemokines 
that promote a proinflammatory environment and likely potentiate neuronal injury. 
The neurotoxic efects of numerous cytokines, chemokines, and viral proteins 
have been extensively characterized in rodent and in vitro models of HIV-associated 
neurologic disease 10,11,161-163. While it is possible that these factors alone could account 
for neuronal dysfunction during early HIV/SIV infection, we were also interested in 
whether other neurotoxic mechanisms were induced during acute disease, as these could 
provide targets for adjuvant therapies aimed at neuroprotection in HIV patients receiving 
cART. Excitoxic neuronal injury due to altered glutamate handling has been implicated 
in the pathogenesis of HAND, as wel as many other neurodegenerative diseases, and 
while there has been much interest in targeting this system therapeuticaly, such 
approaches are complicated by the broad role of glutamate in the CNS 146,148. Recently, 
glutamate has been shown to act as an important neuroglial signaling molecule in the 
PNS, and may impact pain signaling at the level of the sensory ganglia 164-166. We 
therefore hypothesized that local immune activation in the DRG during acute SIV 
infection would be coincident with alterations to the peripheral glutamatergic system, 
which, compared to the CNS, may be more amenable to therapeutic manipulation. 
Nanostring analysis of DRG RNA from 7d SIV-infected macaques revealed significant 
downregulation of the gene encoding the glutaminase enzyme (GLS1), which catalyzes 
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the deamination of glutamine to form glutamate, and upregulation of gene encoding 
glutamine synthetase (GLUL), which converts glutamate to glutamine (Fig 3). Reduced 
glutaminase expression was contrary to what we expected based on previous work 
showing increased glutaminase mRNA in HIV-infected macrophages and microglia 167-
169. However, from a toxicity standpoint, this inverse regulation between glutaminase and 
glutamine synthetase may represent an adaptive host response to protect neurons from 
increased extracelular glutamate in the DRG. Although we were unable to measure 
glutamate levels in the DRG, other groups have shown that HIV-infected macrophages 
release glutamate, and that glutamate is a key mediator of neurotoxicity in vitro 170,171. 
Whether glutamate is also released by SIV-infected macaque macrophages is a topic of 
curent investigation in our lab.  
Changes in glutaminase and glutamine synthetase gene expression in the DRG of 
7d SIV-infected animals were not significantly reflected by Western blot analysis. 
However, it is plausible that this technique was simply not sensitive enough to detect 
subtle changes in total protein concentration in the DRG tissue, or that the assay was 
statisticaly underpowered due to smal group size. It is also worth noting that the amount 
of total protein may not corelate with the level of enzymatic activity, which can be 
altered by post-translational changes. For instance, glutamine synthetase has been shown 
to be particularly vulnerable to oxidative and nitrative modifications, which decrease its 
catalytic activity 172,173. In regards to glutaminase, expression of this enzyme in HIV-
infected macrophages and microglia is quite complex, with diferential regulation among 
isoforms and relocalization of the protein from the mitochondria to the cytosol 167-169, 
thus detailed characterization glutaminase dynamics in the DRG during SIV infection are 
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beyond the scope of the present study, but this remains an important topic for future 
investigations. By conducting immunostaining for glutaminase, we did find that this 
enzyme is highly expressed by the al neuron cel bodies in the DRG, and to a much 
lesser extent in scatered interstitial cels, presumably macrophages. Neither the extent 
nor celular localization of glutaminase immunostaining was appreciably diferent in 
control and 7d SIV-infected DRG. 
In contrast, we observed a clear increase in neuronal glutamine synthetase 
immunoreactivity in the DRG of 7d SIV-infected animals. Immunohistochemical studies 
of the DRG typicaly employ glutamine synthetase as a constitutively expressed, highly 
specific marker of satelite glial cels 174. The situation is similar in the CNS, where 
glutamine synthetase is highly expressed by astrocytes and nearly undetectable in 
neurons under normal physiologic conditions 175. While this altered expression patern 
represents a novel finding in the PNS, there are a limited number of studies describing 
increased glutamine synthetase expression in neurons of the CNS. For example, 
glutamine synthetase expression has been observed in in pyramidal neurons of patients 
with advanced Alzheimer’s disease, likely due to marked impairment of normal 
glutamate handling by nearby astrocytes 176,177, and in cultured rat neurons that have been 
deprived of extracelular glutamine and direct contact with astrocytes 178. Taken together, 
these observations underscore the importance of glutamine as an essential metabolite for 
neuronal cels and suggest that, when the normal source of glutamine is diminished or 
absent, neurons can upregulate glutamine synthetase to meet their metabolic needs. 
Consequently, in the seting of the DRG, neuronal expression of glutamine synthetase 
may reflect depletion of the extracelular glutamine pool by non-neuronal cels 
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undergoing SIV-induced immune activation, and/or dysfunctional glutamate handling by 
the satelite glial cels. In either case, neuronal glutamine synthetase expression likely 
represents a profound shift in metabolic balance within the DRG, which could directly 
contribute to sensory nerve dysfunction and damage during acute SIV infection. 
Moreover, while endogenous glutamine synthetase expression appears to be 
neuroprotective under some conditions in vitro, including oxidative stress and DNA 
damage, it has also been shown to contribute to neuronal death in low-glutamine media 
179. 
Another unexpected finding was decreased expression of βII tubulin in the DRG 
of acutely infected macaques, which was discovered by Western blot. This cytoskeletal 
protein is a microtubule element that is found almost exclusively in neurons and is 
typicaly used as a neuron-specific loading control for protein assays. At this time, we 
have been unable to find another study reporting decreased expression of βII tubulin in 
tissues of the PNS during a disease state, natural or experimental. However, one can 
postulate that a decrease in protein levels without overt neuronal loss (which is not 
evident in the DRG until late stages of disease in our SIV model) or coresponding 
downregulation of the TUBB3 gene (also shown herein by Nanostring), could occur in 
one of three scenarios: 1) increased degradation of the protein, possibly to supply amino 
acids for enhanced metabolic demands, 2) redistribution within the cel, possibly related 
to accelerated transport of the protein from the neuron cel body into the axon, or 3) 
accrual of postranslational modifications that alter binding properties of the primary 
antibody used for the Western blot. We plan to explore these scenarios in more detail in 
future studies.  
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Finaly, we hypothesized that immune activation in the DRG would be 
accompanied by evidence of local oxidative stress. Similar to glutamate excitotoxicity, 
production of excess reactive oxygen species (ROS) in the brain is a potential source of 
neuronal damage in the context of HAND 145,147. Elevated levels of oxidative 
modifications and mitochondrial ROS production have also been detected in the 
peripheral nerves of HIV patients with PN as wel as SIV-infected pigtailed macaques 
with diminished ENFD 180. Using Nanostring analysis, we measured the gene expression 
of two key antioxidant enzymes, SOD1, which localizes primarily to the cytoplasm, and 
SOD2, which is found in the mitochondrial matrix. While there was no diference 
between control and 7d SIV-infected DRG in regards to SOD1 gene expression, there 
were significantly higher levels of SOD2 RNA and protein in the DRG of acutely 
infected animals, suggestive of mitochondria-specific oxidative stress. We initialy 
expected that enhanced SOD2 expression in the DRG would occur primarily within the 
sensory neurons, possibly as a result of mitochondrial injury. However, while there was a 
clear increase in the intensity of SOD2 staining in 7d SIV-infected animals compared to 
controls, it did not localize to neuron cel bodies, but rather the satelite glial cels and 
interstitial macrophages. One explanation for this finding would be that enhanced SOD2 
expression is an adaptive response to increased mitochondrial ROS (mROS) production 
by cels undergoing immune activation. This phenomenon has been explored in 
macrophages and microglia, where production of mROS has been shown to augment 
immune signaling and cytokine production 181,182. However, satelite glial cels, have not 
been studied in detail with resect to mROS.  
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This investigation represents the first comprehensive molecular and morphologic 
analysis of the DRG during acute SIV infection. Although limited by factors inherent to 
macaque studies, such as cross-sectional design, our findings provide valuable insights 
into the origins of sensory nerve dysfunction in HIV. The recognition of the DRG as a 
site of marked local immune activation and potentialy neurotoxic metabolic alterations 
during acute infection, prior to the onset of significant neuropathology or 
neurophysiologic alterations, wil greatly inform future studies on the pathogenesis of 
HIV-SN in the macaque model. Because managing HIV-SN is extremely chalenging 
once neuropathic symptoms are established, efective approaches for preventing sensory 
nerve damage early during HIV infection are urgently needed. A more comprehensive 
understanding of neuropathologic mechanisms induced in the PNS during early HIV 
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kDA of 
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βIII Tubulin Mouse Monoclonal Promega G712A 1:20,000 55 kDa 
β-actin Mouse Monoclonal Sigma A5441 1:20,000 42 kDa 
 
Table 4-1. Primary antibodies used for Western bloting (WB) and 















Goat Dako P0447 1:20,000 
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Figure 4-1. Genes related to immune signaling and activation are upregulated in the 
DRG during acute SIV infection. A-F: Nanostring nCounter gene expression analysis 
revealed marked upregulation of genes involved in immune signaling and the early 
antiviral response in the lumbar DRG 7d SIV-infected animals compared to controls. G: 
Although CCL2 gene expression was elevated in 7d SIV-infected animals, this did not 
reach statistical significance after corecting for multiple comparisons. H: 7d SIV-
infected animals had significantly higher TNFa gene expression in the lumbar DRG, by 
qPCR analysis. Mann Whitney with Bonferoni correction for multiple comparisons 
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Figure 4-2. Celular immune activation in the DRG during acute SIV infection. A: By 
Nanostring gene expression analysis Animals euthanized during acute SIV infection (7d 
SIV) had significantly higher levels of CD68 expression, an indicator of macrophage 
activation, compared to controls. B: Expression of the satelite glial cel activation marker 
GFAP, was also elevated in 7d SIV-infected animals; however this did not reach 
statistical significance after corecting for multiple comparisons. Mann Whitney with 
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Figure 4-3. Expression of genes related to glutamate metabolism and oxidative stress in 
the DRG during acute SIV infection. A-B: By Nanostring gene expression analysis, we 
found significantly decreased glutaminase (GLS) expression and increased glutamine 
synthetase (GLUL) expression in the DRG of 7d SIV-infected macaques compared to 
controls. C-D: While there was no significant diference in DRG SOD1 expression 
between 7d SIV-infected animals and controls, SOD2 was significantly upregulated at 7d 
post SIV infection. Mann Whitney with Bonferoni corection for multiple comparisons 
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Figure 4-4. Quantification of DRG protein expression by Western blot. A: A 
representative Western blot showing DRG homogenates from two control (Control A and 
B) and two 7d SIV-infected macaques (7d SIV A and B) run in duplicate. Protein 
expression levels were quantified by densitometry analysis and normalized to B actin for 
comparison between groups. Protein expression levels for glutaminase (B) and glutamine 
synthetase (C) were not significantly diferent between groups. D: SOD2 protein 
expression was significantly elevated in 7d SIV-infected animals compared to controls. 
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Figure 4-5. βII tubulin expression in the DRG during acute SIV infection. A: 7d SIV 
infected animals had significantly lower DRG βII tubulin expression compared to 
controls. B: There was no significant diference in the level of βII tubulin RNA 
expression (TUBB3) between groups by Nanostring gene expression analysis. Mann 
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Figure 4-6. DRG immunohistochemistry. A-B: Glutaminase expression in both control 
and 7d SIV-infected animals was primarily restricted to the neurons, with difuse, 
moderate to strong cytoplasmic staining of the neuronal cel bodies. Scatered interstitial 
cels, likely macrophages also showed light cytoplasmic reactivity for glutaminase. C-D: 
In uninfected animals, glutamine synthetase expression in the DRG was most apparent in 
the satelite glial cels, with litle to no staining in the neuron cel bodies. In contrast, 7d 
SIV infected ganglia exhibited moderate glutamine synthetase expression in the 
cytoplasm of neuron cel bodies. E-F: SOD2 immunostaining demonstrated difuse, light 
to medium cytoplasmic staining in al cel types in the DRG, with a finely stippled patern 
consistent with mitochondrial localization. In 7d SIV-infected ganglia, there was increase 
in the intensity of SOD2 immunostaining, which localized primarily to the satelite glial 
cels and interstitial macrophages. DAB immunostaining without counterstain. Original 
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Despite widespread use of cART, HIV-SN remains a frequent neurologic 
complication of HIV infection. With prevalence rates as high as 60% in some cohorts, 
HIV-SN represents a vast and growing global health concern 1,23. Because the 
pathogenesis of HIV-SN is complex and dificult to study in human patients, animal 
models of this condition are essential for elucidating the underlying neuropathologic 
mechanisms. Previous work by our laboratory has confirmed that the dual-inoculated 
SIV/macaque model closely recapitulates many of the morphologic and functional 
abnormalities seen in the PNS of HIV patients with neuropathy. The series of studies 
outlined in this dissertation build upon this groundwork by conducting in depth 
morphologic and molecular analyses of multiple components of the sensory pathway, 
namely the ENF, spinal cord, and DRG, and exploring neuropathologic mechanisms 
occuring during both acute and chronic SIV infection.  
The translational value of any animal model is strengthened by the ability to 
employ outcome measures similar to those used in human subjects. In recent years, 
visualization and assessment of ENF in skin biopsies has become a standard clinical tool 
for the diagnosis and monitoring of PN in HIV patients 183. As described in Chapter 2, we 
have adapted this technique for use in Asian macaques and now routinely obtain pre-
infection and necropsy ENF skin biopsies from al SIV study animals, including those 
receiving various cART regimens. The resulting pool of longitudinal ENF data wil be of 
immense value in tracking the impact of host and virus dynamics, as wel as diferent 
antiretroviral drugs, on sensory nerve fiber integrity. In addition, we have also begun to 
use corneal confocal microscopy (CCM) to colect in vivo images of the sub-basal 
corneal nerve plexus from our study macaques, both rhesus and pigtailed. CCM is an 
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emerging, noninvasive clinical tool that is curently being used as a method to diagnose 
and longitudinaly assess neuropathy in patients with diabetes 184,185 and has also been 
employed in rodent models of diabetic neuropathy 186. Our hope is that by pioneering this 
technology in SIV-infected macaques, we wil gain detailed longitudinal information on 
peripheral nerve health and be able to closely track the timing of nerve injury during the 
course of disease and cART, as wel monitor the efects of putative neuroprotective and 
neuroregenerative agents.   
 Chapter 3 of this dissertation addresses the efects of SIV infection on the spinal 
cord, a site where sensory signals can undergo extensive modulation prior to transmission 
to the brain. While the spinal cord remains relatively underepresented in the HIV 
literature, a series of recent reports based on autopsy tissues revealed evidence of 
enhanced glial activation and immune signaling in the spinal cords of HIV patients with 
histories of neuropathic pain 14-16. Similarly, we found that untreated SIV-infected 
macaques exhibited significant elevations in CD68 immunostaining (a marker of 
macrophage/microglial activation) in the spinal cord, as wel as enhanced expression of 
the proinflammatory mediators TNFα and CCL, and that these changes corelated with 
both the amount SIV RNA in the spinal cord and the degree of ENF loss. Also 
compeling was the finding that while SIV RNA was below the level of detection in the 
spinal cord tissue of cART-treated macaques, these animals exhibited marked spinal 
astrocyte activation, as measured by GFAP immunostaining. These significant and 
distinct diferences in the spinal cords of cART-naïve and cART-treated animals suggest 
that the mechanisms leading to central sensitization may be difer between patients with 
uncontroled HIV infection and those receiving efective cART. In future studies, we 
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intend to conduct more detailed analyses on spinal cord tissue of cART-treated 
macaques, including detection of low-copy viral RNA by means of digital droplet PCR, 
as wel as detection of viral DNA, which, in the brain, was not significantly reduced by 
cART in a previous SIV study 38. We also plan to colect more comprehensive gene 
expression data to identify which pro-nociceptive pathways may be persistently 
upregulated in the spinal cords of cART-treated SIV-infected macaques, as this could 
shed light on new therapeutic targets. This could be pursued either by Nanostring gene 
expression analysis, possibly with a redesigned panel of genes related to glial activation 
and pain signaling, or by pathway-focused qPCR assays. 
 Lastly, guided by emerging evidence of significant nervous system impairment in 
patients with early HIV, we chose to investigate alterations in the DRG of animals 
euthanized during acute SIV infection. By conducting Nanostring gene expression 
analysis on lumbar DRG from uninfected control macaques and animals euthanized at 7 
days post infection (dpi), we found that acute SIV infection was associated with marked 
induction of local immune activation in the DRG, as wel as alterations in genes encoding 
enzymes involved in glutamate metabolism and oxidative stress, al of which could 
plausibly contribute to early sensory nerve damage.  
Perhaps the most intriguing observations in Chapter 4 were the unexpected, 
neuron-specific findings of increased glutamine synthetase expression in neuronal cel 
bodies in the DRG (by immunohistochemistry) and decreased βII tubulin expression (by 
Western blot). While these are novel findings in the PNS, increased neuronal glutamine 
synthetase expression has been linked to deficient extracelular glutamine and metabolic 
stress in vitro 178,179, and impairment of astrocytic glutamate handling in the brains of 
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Alzheimer’s patients 177. Accordingly, we propose that glutamine synthetase expression 
by sensory neuron cel bodies is the result of a profound shift in the metabolic 
homeostasis within the DRG during acute SIV infection, possibly due to rapid, intense 
immune activation of the macrophages and satelite glial cels. This premise could also 
account for the decreased βII tubulin expression in the DRG and early ENF decline, as 
metabolicaly-compromised neuronal perikarya may fail to regulate production or 
localization of structural proteins that are necessary to maintain axonal integrity.  
Preliminary analyses of macaques euthanized at progressive time points 
throughout SIV infection (7, 35, 56, and 84 dpi) have shown that glutamine synthetase 
gene expression in the DRG strongly corelates with SIV RNA, GFAP, CD68, and SOD2 
expression (Fig 1), supporting an association between increased glutamine synthetase 
gene expression and SIV-induced immune activation and oxidative stress in the DRG. 
There was also strong inverse corelation between βII tubulin RNA and CD68 gene 
expression (p < 0.001, data not shown); however, in later stages of disease this may be 
atributable to decreased neuronal/axonal density in the DRG with increasing numbers of 
infiltrating activated macrophages. In future studies, I plan to extend these analyses to 
include cART-treated SIV-infected animal. We also hope to develop an in vitro primate 
DRG culture system, similar that employed by Zhu and coleagues 187 in their studies of 
feline immunodeficiency virus (FIV), which would facilitate molecular and 
electrophysiological investigation of cel specific biology and the efects of increased 
glutamine synthetase expression on sensory neuronal health and function.  
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Figures 
 
Figure 5-1. Glutamine synthetase gene expression in the DRG correlates with markers of 
immune activation and oxidative stress. Nanostring gene expression analysis 
demonstrates significant direct corelation between glutamine synthetase (GLUL) 
expression and levels of SIV(A), GFAP (B), CD68 (C), and SOD2 RNA (D) in animals 
euthanized at progressive time points throughout SIV infection. Spearman Rank 
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